<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <atom:link rel="self" type="application/rss+xml" href="https://escholarship.org/uc/ucr_som_clinpop_oapolicydeposits/rss"/>
    <ttl>720</ttl>
    <title>Recent ucr_som_clinpop_oapolicydeposits items</title>
    <link>https://escholarship.org/uc/ucr_som_clinpop_oapolicydeposits/rss</link>
    <description>Recent eScholarship items from Clinical and Population Health Research Open Access Policy Deposits</description>
    <pubDate>Sat, 1 Aug 2026 14:33:32 +0000</pubDate>
    <item>
      <title>Multifocal Renal Infarction and Diabetic Ketoacidosis: Diagnostic Challenges and Anticoagulation Management in a Complex Case.</title>
      <link>https://escholarship.org/uc/item/98s5c7fn</link>
      <description>BACKGROUND Incidental findings of renal infarct secondary to thrombosis in acutely ill patients present a unique challenge in diagnosis. We present a case of idiopathic renal infarct to highlight its workup and management and encourage further investigation of renal infarctions. CASE REPORT A 68-year-old woman with a past medical history of diet-controlled diabetes, hypertension, and hyperlipidemia presented to the Emergency Department (ED) for abdominal pain. She was found to be in diabetic ketoacidosis with pyelonephritis, so she was admitted to the Intensive Care Unit (ICU) for insulin and dextrose drip. Due to her abdominal pain, she underwent computed tomography (CT) of her abdomen and pelvis with contrast. This revealed multifocal infarcts of her right kidney with noncalcified thrombus at the proximal right renal artery. Subsequent CT angiography confirmed a right renal artery thrombus. She was started on subcutaneous enoxaparin and downgraded to basic level of care. Her...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/98s5c7fn</guid>
      <pubDate>Fri, 5 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Miles, Levi</name>
      </author>
      <author>
        <name>Shin, Brandon</name>
      </author>
      <author>
        <name>Ji, Hyein</name>
      </author>
      <author>
        <name>Ghaffari-Rafi, Shadeh</name>
      </author>
      <author>
        <name>Chitsazan, Morteza</name>
      </author>
      <author>
        <name>Kim, Daniel</name>
      </author>
    </item>
    <item>
      <title>Chemosis as an Initial Presentation of Systemic Lupus Erythematosus.</title>
      <link>https://escholarship.org/uc/item/5xx037vh</link>
      <description>Systemic lupus erythematosus (SLE) can present in a multitude of ways, which can be confounding and misleading for a clinician. Chemosis as an initial presentation is rare and has only been documented on a few case reports. However, when present, simultaneous involvement of other organs is likely. We present a previously healthy 29-year-old male who presented with severe bilateral chemosis and was subsequently diagnosed with SLE and antiphospholipid syndrome. Complications included multiple acute cerebral infarcts, lupus psychosis, lupus pleuritis, and lupus nephritis. The patient recovered well with appropriate treatment and chemosis ultimately resolved. Recognizing chemosis as an initial presentation of SLE is vital for appropriate evaluation and timely treatment to prevent disease progression.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5xx037vh</guid>
      <pubDate>Fri, 5 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Luceno, Carvy</name>
      </author>
      <author>
        <name>Yu, Minho</name>
      </author>
      <author>
        <name>Kim, Daniel</name>
      </author>
      <author>
        <name>Sandhu, Vaneet</name>
      </author>
    </item>
    <item>
      <title>Visual Impairment and the Incidence of Concussions Among Youth Football Athletes</title>
      <link>https://escholarship.org/uc/item/8s421125</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;Concussions are a prevalent concern in contact sports, particularly among youth American football players. While extensive research has examined concussion mechanics, the relationship between visual impairment and concussion risk remains understudied.&lt;h4&gt;Purpose&lt;/h4&gt;To investigate the incidence of concussions among visually impaired versus non-visually impaired youth football players to inform clinical practice and preventive measures.&lt;h4&gt;Study design&lt;/h4&gt;Cohort study; Level of evidence, 3.&lt;h4&gt;Methods&lt;/h4&gt;A retrospective cohort study was performed using the TriNetX US Collaborative Network. Pediatric athletes aged 5 to 17 years with documented football participation were identified using International Classification of Diseases, Tenth Revision, codes. Visual impairment (H46-H47, H52-H54) was required to precede the index football encounter by ≥1 month. Concussions (S06.0) and concussion with loss of consciousness (LOC) (S06.0X1-S06.0X9) were assessed within...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8s421125</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Jamaleddine, Karim</name>
      </author>
      <author>
        <name>Gad El Sayed, Marina</name>
      </author>
      <author>
        <name>Novak, Daniel</name>
        <uri>https://orcid.org/0000-0001-8559-3244</uri>
      </author>
      <author>
        <name>Goodman, Aubree</name>
      </author>
      <author>
        <name>Helms, Jackson</name>
      </author>
      <author>
        <name>Schlechter, John</name>
      </author>
    </item>
    <item>
      <title>Screening for Toxic Stress Response and Buffering Factors: A Case-Based, Trauma-Informed Approach to Health Equity</title>
      <link>https://escholarship.org/uc/item/1sv615pc</link>
      <description>Introduction: Exposure to adverse childhood experiences (ACEs) can lead to a toxic stress response with impacts on health that affect health equity. As part of our Health Equity, Social Justice, and Anti-racism curriculum, our aim was to introduce second-year medical students to a case-based method using a template-based screening and application of toxic stress, buffering factors, and resiliency-fostering tools to address health disparities and inequities with a trauma-informed care approach.
Methods: We developed an asynchronous e-learning module that demonstrated the impact of ACEs by introducing students to screening for toxic stress response and buffering factors on health, their role as health equity determinants, and the use of brief in-clinic resilience-fostering tools in patient care. This was followed by a synchronous, facilitated, small-group, virtual discussion of a clinical case. Pre- and postworkshop surveys assessed changes in knowledge, skills, and attitudes. A...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1sv615pc</guid>
      <pubDate>Thu, 4 Jun 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Osei, Adwoa</name>
        <uri>https://orcid.org/0000-0003-4548-1381</uri>
      </author>
      <author>
        <name>Paz, Camila Garcia</name>
      </author>
      <author>
        <name>Stuparich, Mallory</name>
      </author>
      <author>
        <name>Racataian-Gavan, Rebeca</name>
      </author>
      <author>
        <name>Nelms, Laurel</name>
      </author>
      <author>
        <name>Suliman, Yasmine</name>
      </author>
      <author>
        <name>Smith, Amanda</name>
      </author>
      <author>
        <name>Bajwa, Moazzum</name>
      </author>
    </item>
    <item>
      <title>COVID-19 associated rhabdomyolysis leading to major amputation in the absence of macrovascular thrombosis.</title>
      <link>https://escholarship.org/uc/item/7t8143fx</link>
      <description>A 50 year old patient presented with bilateral lower extremity weakness, lethargy, and dyspnea. Nasopharyngeal swab was positive for SARS-CoV-2. She progressed to acute hypoxemic respiratory failure and hemodynamic instability requiring intubation, pressor support, and hemodialysis. Maculopapular rashes developed on bilateral lower extremities with progressively worsening rhabdomyolysis. Bilateral lower extremity fasciotomies were performed with subsequent serial operative debridements to remove necrotic muscle. One month later, she required a right above knee amputation. There was no evidence of macrovascular thrombosis. A high clinical suspicion of rhabdomyolysis in COVID-19 patients is necessary to avoid major limb loss.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7t8143fx</guid>
      <pubDate>Thu, 21 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Kar, Rahul</name>
      </author>
      <author>
        <name>Murga, Allen</name>
      </author>
      <author>
        <name>Teruya, Theodore</name>
      </author>
      <author>
        <name>Patel, Sheela</name>
      </author>
    </item>
    <item>
      <title>FamilyBloom: Examining Ecologies of Collaboration in Family-Centered Health Tracking</title>
      <link>https://escholarship.org/uc/item/2hs1f70b</link>
      <description>Family health informatics tools can help support well-being with shared data tracking. Prior work typically focused on shared data review, but often in specific moments, like bedtime, or centered on caregiving of children or elderly members. To investigate how tracking can support mutual health collaboration between family members pervasively across daily contexts, we designed and deployed FamilyBloom, a glanceable smartwatch and home display system for mood and goal tracking. Twelve families with both neurotypical and ADHD members used FamilyBloom for three months on average. Our findings reveal how family-centered tracking created collaboration opportunities and tensions across multiple ecological systems: individual self-regulation, collaborations within family dynamics, involvement of care networks with varying trust levels, institutional school constraints and cultural stigma, and temporality of regular routines and crisis periods. We discuss an ecosystem-aware approach to...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2hs1f70b</guid>
      <pubDate>Wed, 6 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Silva, Lucas M</name>
      </author>
      <author>
        <name>Min, Aehong</name>
        <uri>https://orcid.org/0000-0002-3790-2126</uri>
      </author>
      <author>
        <name>Stefanidi, Evropi</name>
      </author>
      <author>
        <name>Cibrian, Franceli L</name>
      </author>
      <author>
        <name>Beltran, Jesus A</name>
      </author>
      <author>
        <name>Zeiler, Cassie</name>
      </author>
      <author>
        <name>Schuck, Sabrina</name>
      </author>
      <author>
        <name>Lakes, Kimberley D</name>
      </author>
      <author>
        <name>Hayes, Gillian R</name>
      </author>
      <author>
        <name>Epstein, Daniel A</name>
        <uri>https://orcid.org/0000-0002-2657-6345</uri>
      </author>
    </item>
    <item>
      <title>Developing health care provider knowledge, confidence, and cultural sensitivity through resident transgender training: a controlled educational study</title>
      <link>https://escholarship.org/uc/item/03x3b613</link>
      <description>BackgroundTransgender and gender-diverse (TGD) individuals face substantial health disparities as a result of discrimination and poor provider competence in understanding their health needs. Relatively little work has been done studying educational interventions targeted toward increasing residents’ knowledge and ability to treat TGD individuals with sensitivity. We studied the effectiveness of implementing a lecture series on transgender health in preparing internal medicine residents to care for the TGD population.MethodsBoth study and control participants were recruited through their affiliated internal medicine residency programs. The study design was a pre-post controlled educational study. A lecture series was developed at Riverside University Health System as the educational intervention. We used a Transgender Assessment survey developed for the study to determine changes in the residents’ knowledge, self-confidence, and knowledge of barriers to care during the study period...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/03x3b613</guid>
      <pubDate>Wed, 6 May 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Huang, Kathie</name>
      </author>
      <author>
        <name>Yang, Almira J</name>
      </author>
      <author>
        <name>Skoretz, Lynnetta</name>
      </author>
      <author>
        <name>Firek, Anthony</name>
        <uri>https://orcid.org/0000-0001-6649-2798</uri>
      </author>
      <author>
        <name>Khurana, Dhruv</name>
        <uri>https://orcid.org/0000-0002-3108-9517</uri>
      </author>
    </item>
    <item>
      <title>TEACHING AND ADVANCING SUBSTANCE USE CARE FOR ADOLESCENTS AND YOUNG ADULTS</title>
      <link>https://escholarship.org/uc/item/8xv770ch</link>
      <description>TEACHING AND ADVANCING SUBSTANCE USE CARE FOR ADOLESCENTS AND YOUNG ADULTS</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8xv770ch</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Fortuna, Lisa R</name>
        <uri>https://orcid.org/0000-0002-5336-4970</uri>
      </author>
      <author>
        <name>Tyrrell, Rosemary</name>
      </author>
      <author>
        <name>Porche, Michelle V</name>
      </author>
    </item>
    <item>
      <title>University of California, Riverside School of Medicine.</title>
      <link>https://escholarship.org/uc/item/4439s9qv</link>
      <description>University of California, Riverside School of Medicine.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4439s9qv</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Willis, Brigham C</name>
      </author>
      <author>
        <name>Lytle, Christian</name>
      </author>
      <author>
        <name>Dupper, Maegen</name>
      </author>
      <author>
        <name>Tyrrell, Rosemary</name>
      </author>
      <author>
        <name>Morrison, Elizabeth H</name>
      </author>
      <author>
        <name>Davis, Kendrick</name>
      </author>
      <author>
        <name>Barton, Kathy</name>
      </author>
      <author>
        <name>Deas, Deborah</name>
      </author>
    </item>
    <item>
      <title>Defining Immersive Learning</title>
      <link>https://escholarship.org/uc/item/0p26320s</link>
      <description>Immersive learning practices (ILPs) in higher education are multidisciplinary in nature and varied in levels of integration into the student learning process. They appear in a variety of higher education programs such as teacher education, social work, law, and health sciences, and in practices such as service-learning, study away, internships, and foreign-language instruction. Based on observations of teaching and data from an open-ended survey and semi-structured interviews with post-secondary educators from three different countries, this study theorizes that immersive learning practices are composed of six distinct underlying theoretical components that work in combination. These six components can be used to describe, define, compare, and design different types of structured ILPs. This study suggests that ILPs are pedagogically distinct from other forms of engaged and experiential learning.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0p26320s</guid>
      <pubDate>Thu, 23 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Motley, Phillip</name>
      </author>
      <author>
        <name>Archer-Kuhn, Beth</name>
      </author>
      <author>
        <name>Hondzel, Catharine Dishke</name>
      </author>
      <author>
        <name>Dobbs-Oates, Jennifer</name>
      </author>
      <author>
        <name>Eady, Michelle</name>
      </author>
      <author>
        <name>Seeley, Janel</name>
      </author>
      <author>
        <name>Tyrrell, Rosemary</name>
      </author>
    </item>
    <item>
      <title>Supporting Basic Psychological Needs in Medical Education: A Patient Best Practice.</title>
      <link>https://escholarship.org/uc/item/5kb3572n</link>
      <description>Physician burnout remains a pervasive challenge in medical education, with significant implications for both physician well-being and the quality and safety of patient care. Despite growing awareness and interventions, medical educators often lack a cohesive theoretical framework that explains how learning environments can contribute to both burnout and clinical performance. This article highlights Self-Determination Theory (SDT) as a robust, evidence-based lens through which to understand and address these challenges by emphasizing the fulfillment of three basic psychological needs: autonomy, competence, and relatedness. Drawing on foundational and contemporary research across health professions education and healthcare, the authors argue that supporting these needs within clinical learning environments not only enhances learner motivation, engagement, and resilience, but also reduces burnout and its downstream effects on empathy, decision-making, teamwork, and patient outcomes....</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5kb3572n</guid>
      <pubDate>Fri, 17 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Neufeld, Adam</name>
      </author>
      <author>
        <name>Guldner, Gregory</name>
      </author>
    </item>
    <item>
      <title>PATIENT OUTCOMES AFTER BEING TREATED WITH BETA-BLOCKERS FOR HEART RATE CONTROL IN SEPTIC SHOCK</title>
      <link>https://escholarship.org/uc/item/1rk9g9zr</link>
      <description>PATIENT OUTCOMES AFTER BEING TREATED WITH BETA-BLOCKERS FOR HEART RATE CONTROL IN SEPTIC SHOCK</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1rk9g9zr</guid>
      <pubDate>Thu, 9 Apr 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Mourkus, Avrodet</name>
      </author>
      <author>
        <name>Mourkus, Avronia</name>
      </author>
      <author>
        <name>Graham, Darby</name>
      </author>
      <author>
        <name>Rajotia, Arush</name>
      </author>
      <author>
        <name>Novak, Daniel</name>
      </author>
      <author>
        <name>Tabibian, Benjamin</name>
      </author>
    </item>
    <item>
      <title>Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records.</title>
      <link>https://escholarship.org/uc/item/9k99s6g1</link>
      <description>BackgroundEvidence from observational studies and randomized controlled trials (RCTs) remains discordant on the impact of statin therapy on long-term outcomes related to Alzheimer's disease. Observational studies find relatively large effect sizes; RCTs fail to demonstrate cognitive benefits. Methodological limitations in both approaches may explain the disconnect.ObjectiveTo bridge the gap between observational and RCT studies, this study uses Real World Data (RWD) to evaluate the association between statin use and incident AD risk, and contributes additional detailed stratification by statin type and dosage.MethodsThis observational analysis of EHR data from over 125 million U.S. patients through the TriNetX platform compared statin exposure in adults over 45 years old with a diagnosis of dyslipidemia, and no prior AD diagnosis, controlling for demographics, a range of known comorbidities, laboratory values, and medications. Primary outcomes were incident AD, other degenerative...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9k99s6g1</guid>
      <pubDate>Thu, 12 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Novak, Daniel A</name>
      </author>
      <author>
        <name>Saleem, Najia</name>
      </author>
      <author>
        <name>Gerhardt, Paul C</name>
      </author>
      <author>
        <name>Maestas, Drake</name>
      </author>
      <author>
        <name>Kejriwal, Nidhi</name>
      </author>
      <author>
        <name>Vaezazizi, Elisa</name>
      </author>
      <author>
        <name>Murray, Ian</name>
      </author>
      <author>
        <name>Al-Khoury, Lama</name>
      </author>
    </item>
    <item>
      <title>Exogenous Sex Hormones and Postoperative Nausea and Vomiting Risk in Transgender Patients</title>
      <link>https://escholarship.org/uc/item/26q5p1vx</link>
      <description>BACKGROUND: Postoperative nausea and vomiting (PONV) remain a significant consideration in perioperative care; however, the incidence and risk factors of PONV in transgender patients are poorly understood. This study investigated the rates of PONV in transgender patients receiving gender-affirming hormone therapy (GAHT) compared to cisgender patients. We postulate that exogenous testosterone GAHT reduces the risk of PONV while exogenous estrogen GAHT increases the risk of PONV.   METHODS: This retrospective cohort study was conducted using the TriNetX database. Patients were divided into 2 groups: transgender and cisgender. Separate analyses were performed for hysterectomies (transgender male [assigned female at birth, AFAB] versus cisgender female), orchiectomies (transgender female [assigned male at birth, AMAB] versus cisgender male), and augmentation mammoplasties (transgender female [AMAB] versus cisgender female). Propensity score matching was performed for age, race, and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/26q5p1vx</guid>
      <pubDate>Thu, 12 Mar 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Soloniuk, Leonard J</name>
      </author>
      <author>
        <name>Sran, Jasmine</name>
      </author>
      <author>
        <name>Baker, Christopher</name>
      </author>
      <author>
        <name>Kim, Andrew</name>
      </author>
      <author>
        <name>Han, Blake</name>
      </author>
      <author>
        <name>Canumay, Sallie</name>
      </author>
      <author>
        <name>Novak, Daniel</name>
      </author>
      <author>
        <name>Sinha, Ashish C</name>
      </author>
      <author>
        <name>Stier, Gary</name>
      </author>
    </item>
    <item>
      <title>Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability</title>
      <link>https://escholarship.org/uc/item/3j77w934</link>
      <description>INTRODUCTION: To avoid bias and optimize statistical power of disease-modifying therapeutic trials, it is critical to include homogeneous populations with similar rate of progression over time. Patients with Progressive Supranuclear Palsy (PSP)-Parkinsonism phenotype have overall slower disease progression than those with PSP-Richardson syndrome phenotype. However, it is unclear if the progression rate of PSP-Parkinsonism is the same when the PSP-Parkinsonism converts to PSP Richardson syndrome. We aimed to determine and compare disease progression rate of patients with the two most common PSP phenotypes: PSP-Parkinsonism and PSP Richardson syndrome, participating in the TAUROS trial.
METHODS: 138 patients, 56 with PSP-Parkinsonism and 82 with PSP-Richardson syndrome, with similar clinical severity at baseline, were followed up to 60 weeks. PSP-Parkinsonism allocation was based on experts' judgement and PSP-Richardson on probable NINDS-PSP criteria. Global disease progression...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3j77w934</guid>
      <pubDate>Tue, 24 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Shoeibi, Ali</name>
      </author>
      <author>
        <name>Litvan, Irene</name>
        <uri>https://orcid.org/0000-0002-3485-3445</uri>
      </author>
      <author>
        <name>Tolosa, Eduardo</name>
      </author>
      <author>
        <name>del Ser, Teodoro</name>
      </author>
      <author>
        <name>Lee, Euyhyun</name>
      </author>
      <author>
        <name>Investigators, TAUROS</name>
      </author>
    </item>
    <item>
      <title>Poster 296 AbobotulinumtoxinA Injection Patterns in Patients with Cervical Dystonia from the ANCHOR‐CD Registry Study</title>
      <link>https://escholarship.org/uc/item/1xr4c96t</link>
      <description>Poster 296 AbobotulinumtoxinA Injection Patterns in Patients with Cervical Dystonia from the ANCHOR‐CD Registry Study</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1xr4c96t</guid>
      <pubDate>Tue, 24 Feb 2026 00:00:00 +0000</pubDate>
      <author>
        <name>Comella, Cynthia L</name>
      </author>
      <author>
        <name>Camba, George C</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Espay, Alberto J</name>
      </author>
      <author>
        <name>Snyder, Daniel</name>
      </author>
      <author>
        <name>Marchese, Dominic</name>
      </author>
      <author>
        <name>Trosch, Richard</name>
      </author>
    </item>
    <item>
      <title>Renewing Multicultural Education: An Ancient Mariner’s Manifesto</title>
      <link>https://escholarship.org/uc/item/1c63d6fk</link>
      <description>Renewing Multicultural Education: An Ancient Mariner’s Manifesto</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1c63d6fk</guid>
      <pubDate>Tue, 9 Dec 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cortés, Carlos E</name>
      </author>
    </item>
    <item>
      <title>Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and Surveillance</title>
      <link>https://escholarship.org/uc/item/8dz9p8sc</link>
      <description>Bladder cancer is a prevalent malignancy with high morbidity and mortality, particularly when diagnosed at an advanced stage. Early detection is critical, as it significantly improves prognosis and the patient’s outcomes. Bladder cancer also has a high recurrence rate, necessitating long-term surveillance. While cystoscopy remains the gold standard for diagnosis and monitoring, it is invasive and costly. Urine cytology, though widely used, has high specificity for detecting high-grade urothelial carcinoma but suffers from low sensitivity and limited effectiveness as a stand-alone diagnostic tool. Urinary biomarkers offer a promising, noninvasive alternative for early detection and disease surveillance. This review examines FDA-approved urinary biomarker tests, including NMP 22, UroVysion, and BTA, highlighting their clinical utility and limitations. Additionally, we explore emerging biomarkers such as DNA methylation assays, genomic alterations, and proteomic signatures as well...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8dz9p8sc</guid>
      <pubDate>Thu, 20 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Yang, Zhenyun</name>
      </author>
      <author>
        <name>Song, Fengyu</name>
      </author>
      <author>
        <name>Zhong, Jin</name>
      </author>
    </item>
    <item>
      <title>Emergency Department Survey of Vaccination Knowledge, Vaccination Coverage, and Willingness to Receive Vaccines in an Emergency Department Among Underserved Populations - Eight US Cities, April-December, 2024</title>
      <link>https://escholarship.org/uc/item/7wn3d1sp</link>
      <description>Emergency Department Survey of Vaccination Knowledge, Vaccination Coverage, and Willingness to Receive Vaccines in an Emergency Department Among Underserved Populations - Eight US Cities, April-December, 2024</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7wn3d1sp</guid>
      <pubDate>Thu, 20 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Torres, Jesus R</name>
      </author>
      <author>
        <name>Chinnock, Brian</name>
      </author>
      <author>
        <name>Kean, Efrat</name>
      </author>
      <author>
        <name>Rising, Kristin L</name>
      </author>
      <author>
        <name>Conn, Christopher</name>
      </author>
      <author>
        <name>Gottlieb, Michael</name>
      </author>
      <author>
        <name>Sekar, Shwetha</name>
      </author>
      <author>
        <name>Gomez, Perla</name>
      </author>
      <author>
        <name>Olivera, Lorenia</name>
      </author>
      <author>
        <name>Eucker, Stephanie A</name>
      </author>
      <author>
        <name>Difulvio, Sofia</name>
      </author>
      <author>
        <name>Alvarez, Christopher</name>
      </author>
      <author>
        <name>Molina, Melanie F</name>
      </author>
      <author>
        <name>Ge, Shaokui</name>
      </author>
      <author>
        <name>Kumar, Vijaya Arun</name>
      </author>
    </item>
    <item>
      <title>The I-ACTED study (investigating action civics training through an experimental design): a cluster randomized controlled trial of a school-based action civics education intervention on adolescent wellbeing</title>
      <link>https://escholarship.org/uc/item/9094g0c3</link>
      <description>BackgroundObservational studies have found that youth civic engagement is associated with positive mental health, education, and socioeconomic outcomes. However, access to civic opportunities is not evenly distributed. Many classrooms in the United States of America (USA) do not have access to high-quality civics education. Action civics approaches to civic education prepare students for civic engagement by developing the necessary civic skills, knowledge, and character. Through action civics, classes take action on a real-world issue students choose together. Some evidence suggests that action civics may positively affect participants’ wellbeing through the feelings of civic connection and empowerment. The aim of this study is to investigate, through a randomized controlled trial, the impact of a school-based action civics education intervention on civic and wellbeing outcomes, and the mechanisms of any impact observed, among middle and high school students in the USA.MethodsThis...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9094g0c3</guid>
      <pubDate>Thu, 6 Nov 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cohen, Alison K</name>
      </author>
      <author>
        <name>Fitzgerald, Jason C</name>
      </author>
      <author>
        <name>Trejo, Grisel</name>
      </author>
      <author>
        <name>Yalif, Isabella U</name>
      </author>
      <author>
        <name>Wesson, Paul D</name>
      </author>
      <author>
        <name>Wolfson, Mark</name>
      </author>
      <author>
        <name>Ballard, Parissa J</name>
      </author>
    </item>
    <item>
      <title>Upholding the Human Rights and Well-Being of Refugee Children Through Effective Clinical Care</title>
      <link>https://escholarship.org/uc/item/5n56n8nn</link>
      <description>Refugee children are often exposed to adversities and traumatic experiences that can harm the mental health and well-being of refugee children. These include human trafficking and exploitation and dangers in detention centers and refugee camps. All these adverse events can be traumatic and contribute to poor mental health, including posttraumatic stress, anxiety, depression, and substance use disorders. Therefore, the assessment of refugee children and adolescents should include screening and identification for these experiences, provision of evidence-based trauma treatment, and social supports to promote their well-being and thriving.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5n56n8nn</guid>
      <pubDate>Wed, 29 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Fortuna, Lisa R</name>
      </author>
      <author>
        <name>Porche, Michelle V</name>
      </author>
    </item>
    <item>
      <title>Comparison of 5-year incidence of subsequent primary malignancies among patients with melanoma vs basal cell carcinoma: A gender-stratified propensity score-matched cohort study</title>
      <link>https://escholarship.org/uc/item/731710gh</link>
      <description>Comparison of 5-year incidence of subsequent primary malignancies among patients with melanoma vs basal cell carcinoma: A gender-stratified propensity score-matched cohort study</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/731710gh</guid>
      <pubDate>Thu, 9 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Pham, Donna</name>
      </author>
      <author>
        <name>Salas, Jesse</name>
      </author>
      <author>
        <name>Chow, Conroy</name>
      </author>
      <author>
        <name>Novak, Daniel</name>
      </author>
      <author>
        <name>Elsensohn, Ashley</name>
      </author>
    </item>
    <item>
      <title>Pediatric Non-Cystic Fibrosis Pulmonary Nontuberculous Mycobacterium Infections: A Global Population Based Study</title>
      <link>https://escholarship.org/uc/item/5kb7x79b</link>
      <description>Background: Nontuberculous mycobacteria (NTM) are Mycobacterial pathogens that cause pulmonary infections among children, particularly those with underlying lung conditions or immunosuppression. Clinical presentations include chronic cough, weight loss, and fatigue. Diagnosis involves clinical assessment, radiographic imaging, and microbiological confirmation, while treatment often requires prolonged, multidrug antibiotic regimens. This study aimed to analyze the epidemiology and clinical outcomes of pulmonary NTM infections in a non-cystic fibrosis pediatric population from four distinct age groups.
Methods: A retrospective study as cross-sectional design for data collection from the TriNetX platform, a global electronic health record database. Inclusion criteria targeted pediatric patients aged 0-18 years with pulmonary NTM, while exclusion criteria included cystic fibrosis, tuberculosis, smoking history, and cutaneous NTM infections. The cohort comprised 109 cases among 0-2...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5kb7x79b</guid>
      <pubDate>Thu, 9 Oct 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Sayed, Marina Bahaa Monir Zakhary Gad El</name>
      </author>
      <author>
        <name>Tai, Dennis</name>
      </author>
      <author>
        <name>Yu, Lucy</name>
      </author>
      <author>
        <name>Novak, Daniel</name>
      </author>
      <author>
        <name>Dosanjh, Amrita</name>
      </author>
    </item>
    <item>
      <title>Policy stakeholders' perspectives and use of data, research evidence, and misinformation in three counties in California, USA during the COVID-19 pandemic, 2020–2022</title>
      <link>https://escholarship.org/uc/item/6cp5327g</link>
      <description>Objective: This study investigates how local policy stakeholders viewed and used research evidence, data, and (mis)information in county policy discussions during the COVID-19 pandemic.
Method: We employed document and exploratory content analysis methods to examine Board of Supervisor materials (&lt;i&gt;N&lt;/i&gt;&amp;nbsp;=&amp;nbsp;534 policy documents) from general and special/emergency meetings (March 2020 - December 2022). We purposefully selected three jurisdictions from California, USA with varying socio-demographic, political, and health care characteristics as case studies.
Results: Many residents who commented during local policy discussions contested the: 1) validity of health data provided (i.e., mortality rates), and 2) efficacy of proposed preventive measures like mask wearing and vaccine receipt. While government officials and healthcare personnel referenced research evidence and data as justification for these measures, several stakeholders expressed skepticism about the information...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6cp5327g</guid>
      <pubDate>Wed, 24 Sep 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Murillo, Joshua</name>
      </author>
      <author>
        <name>Pulido, Tessa R</name>
      </author>
      <author>
        <name>Loyd, Aerika Brittian</name>
      </author>
      <author>
        <name>Subica, Andrew M</name>
        <uri>https://orcid.org/0000-0001-6424-7668</uri>
      </author>
      <author>
        <name>Yen, Irene H</name>
      </author>
      <author>
        <name>Payán, Denise D</name>
      </author>
    </item>
    <item>
      <title>Revisiting the ‘sterilising cure’ terminology: a call for more patient-centred perspectives on HIV cure-related research</title>
      <link>https://escholarship.org/uc/item/9h1252n9</link>
      <description>The literature on HIV therapeutics research is rife with terminology associating 'sterilisation' with HIV cure. We find connotations of the word 'sterilising' problematic for the HIV cure research field. In this viewpoint, we review associations of sterilising with concepts of disinfection or cleansing, as well as coerced sterilisation. We discuss emerging findings from socio-behavioural research that show aversion from people living with HIV towards the 'sterilising cure' nomenclature. We call for more collaborations with people with HIV as partners to help define what would be a more acceptable terminology for describing an HIV cure.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9h1252n9</guid>
      <pubDate>Wed, 20 Aug 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Newton, Luke</name>
      </author>
      <author>
        <name>Necochea, Raúl</name>
      </author>
      <author>
        <name>Palm, David</name>
      </author>
      <author>
        <name>Taylor, Jeff</name>
      </author>
      <author>
        <name>Barr, Liz</name>
      </author>
      <author>
        <name>Patel, Hursch</name>
      </author>
      <author>
        <name>Nathan, Anshula</name>
      </author>
      <author>
        <name>Gerrard, Jo</name>
        <uri>https://orcid.org/0009-0003-2364-4327</uri>
      </author>
      <author>
        <name>Sylla, Laurie</name>
      </author>
      <author>
        <name>Brown, Brandon</name>
      </author>
      <author>
        <name>Dubé, Karine</name>
      </author>
    </item>
    <item>
      <title>Understanding Opioid Use from Retrospective Accounts of Young Adults in Recovery: Motives, Experiences, and Implications for Prevention</title>
      <link>https://escholarship.org/uc/item/7t95j5gk</link>
      <description>Opioid use disorder is a public health problem with disastrous effects for young people and their families. Opioid use shares risk factors with other substances; there may be additional unique motives and experiences associated with opioid use with potential implications for improving prevention. The present study used surveys and interviews to elicit retrospective accounts of 30 young adults (19 female) in recovery from opioid use disorder to examine (1) self-reported motives for opioid use, and (2) experiences and factors that participants associate with opioid use as compared to other substances. Motives reported for past opioid use on surveys were enhancement (i.e., fun or excitement) and coping (i.e., to forget worries or cheer up when in a bad mood), followed by conformity and social motives. Through analysis of interview data, we found that: experiences of opioid use differed from experiences associated with other substances, with effects described in terms of escape and...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7t95j5gk</guid>
      <pubDate>Thu, 17 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Ballard, Parissa J</name>
      </author>
      <author>
        <name>Vidrascu, Elena M</name>
      </author>
      <author>
        <name>Arnold, Taylor J</name>
      </author>
      <author>
        <name>Hernandez, Guadalupe C</name>
      </author>
      <author>
        <name>Ozer, Emily J</name>
      </author>
      <author>
        <name>Lassiter, Rebekah</name>
      </author>
      <author>
        <name>Nayyar, Himani</name>
      </author>
      <author>
        <name>Daniel, Stephanie S</name>
      </author>
      <author>
        <name>Wolfson, Mark</name>
      </author>
    </item>
    <item>
      <title>UCLA International Medical Graduate Pathway to Family Medicine Board Certification and Underserved Practice.</title>
      <link>https://escholarship.org/uc/item/5jj5c7kq</link>
      <description>BACKGROUND AND OBJECTIVES: The University of California, Los Angeles (UCLA) International Medical Graduate (IMG) program addresses the need for more bilingual and bicultural Latino family physicians in California where Latinos are the largest racial/ethnic minority group and a large percentage of the population speaks Spanish. The objective of this descriptive study was to assess family medicine residency match, board certification, and initial practice location outcomes of the program graduates.
METHODS: We conducted a cross-sectional study of program graduates (N=204) from 2007 to 2024. Data were abstracted from program administrative files and the California Medical Board. Primary outcomes were match rate into California family medicine residency programs, completion of a residency, board certification, and initial training practice location. We computed descriptive statistics for participant characteristics and outcomes.
RESULTS: A total of 177/204 (87%) participants completed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5jj5c7kq</guid>
      <pubDate>Thu, 17 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bholat, Michelle</name>
      </author>
      <author>
        <name>Hernandez, Ann M</name>
      </author>
      <author>
        <name>Campos, Blanca</name>
      </author>
      <author>
        <name>Antillon, Ricardo</name>
      </author>
      <author>
        <name>Dowling, Patrick T</name>
      </author>
      <author>
        <name>Moreno, Gerardo</name>
      </author>
    </item>
    <item>
      <title>Transitioning between institutions: Social (re)location and positionality in student veteran health and well-being</title>
      <link>https://escholarship.org/uc/item/42n1t2jq</link>
      <description>Transitioning between institutions: Social (re)location and positionality in student veteran health and well-being</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/42n1t2jq</guid>
      <pubDate>Thu, 17 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Cheney, Ann Marie</name>
        <uri>https://orcid.org/0000-0002-4032-6692</uri>
      </author>
      <author>
        <name>Ahmadpoor, Xenab</name>
      </author>
      <author>
        <name>Rotondi, Matthew Baron</name>
      </author>
      <author>
        <name>Lane, David</name>
      </author>
      <author>
        <name>Curran, Geoffrey M</name>
      </author>
    </item>
    <item>
      <title>Association of SARS-CoV-2 With Health-related Quality of Life 1 Year After Illness Using Latent Transition Analysis</title>
      <link>https://escholarship.org/uc/item/71s975m8</link>
      <description>Background: Long-term sequelae after SARS-CoV-2 infection may impact health-related quality-of-life (HRQoL), yet it is unknown how HRQoL changes during recovery. We compared patient-reported HRQoL among adults with COVID-19-like illness who tested SARS-CoV-2 positive (COVID+) with those who tested negative (COVID-).
Methods: Participants in this prospective, multicenter, longitudinal registry study were enrolled from December 2020 through August 2022 and completed 3-month follow-up assessments until 12 months after enrollment. Participants were adults (≥18 years) with acute symptoms suggestive of COVID-19 who received a Food and Drug Administration-approved SARS-CoV-2 test. Participants received questions from PROMIS-29 (subscales: physical function, anxiety, depression, fatigue, social participation, sleep disturbance, and pain interference) and PROMIS SF-8a (cognitive function). Latent transition analysis was used to identify meaningful patterns in HRQoL scores over time; 4...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/71s975m8</guid>
      <pubDate>Wed, 2 Jul 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Wisk, Lauren E</name>
        <uri>https://orcid.org/0000-0003-2932-4140</uri>
      </author>
      <author>
        <name>Gottlieb, Michael</name>
      </author>
      <author>
        <name>Chen, Peizheng</name>
      </author>
      <author>
        <name>Yu, Huihui</name>
      </author>
      <author>
        <name>O’Laughlin, Kelli N</name>
      </author>
      <author>
        <name>Stephens, Kari A</name>
      </author>
      <author>
        <name>Nichol, Graham</name>
      </author>
      <author>
        <name>Montoy, Juan Carlos C</name>
        <uri>https://orcid.org/0000-0001-7438-0243</uri>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Santangelo, Michelle</name>
      </author>
      <author>
        <name>Gatling, Kristyn</name>
      </author>
      <author>
        <name>Spatz, Erica S</name>
      </author>
      <author>
        <name>Venkatesh, Arjun K</name>
      </author>
      <author>
        <name>Rising, Kristin L</name>
      </author>
      <author>
        <name>Hill, Mandy J</name>
      </author>
      <author>
        <name>Huebinger, Ryan</name>
      </author>
      <author>
        <name>Idris, Ahamed H</name>
      </author>
      <author>
        <name>Willis, Michael</name>
      </author>
      <author>
        <name>Kean, Efrat</name>
      </author>
      <author>
        <name>McDonald, Samuel A</name>
      </author>
      <author>
        <name>Elmore, Joann G</name>
        <uri>https://orcid.org/0000-0002-7311-6835</uri>
      </author>
      <author>
        <name>Weinstein, Robert A</name>
      </author>
    </item>
    <item>
      <title>Voicing student recovery: Embracing diversity in collegiate recovery programs</title>
      <link>https://escholarship.org/uc/item/6r3811jr</link>
      <description>&lt;b&gt;Objective:&lt;/b&gt; To discuss the engagement of patients and stakeholders (ie, faculty, staff, healthcare providers, and university administrators) in capacity building activities to prepare for future patient-centered research on collegiate recovery. &lt;b&gt;Participants:&lt;/b&gt; 502 attended capacity building activities and provided input on priorities for future research in collegiate recovery and 77 participated in the deliberative democracy forum process. &lt;b&gt;Methods:&lt;/b&gt; We used surveys and the deliberative democracy forum method, which includes framing sessions and forums for data collection. This method enables individuals with diverse backgrounds to share and learn about differing viewpoints to build consensus for decision making. &lt;b&gt;Results:&lt;/b&gt; Forum participants prioritized barriers to recovery for future research and discussed the need to address diversity in collegiate recovery programs, including racial/ethnic diversity in the student recovery population and diversity in pathways...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6r3811jr</guid>
      <pubDate>Tue, 13 May 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Vázquez, Evelyn</name>
      </author>
      <author>
        <name>Nieri, Tanya</name>
        <uri>https://orcid.org/0000-0002-5878-1802</uri>
      </author>
      <author>
        <name>Fernandes, Frances</name>
      </author>
      <author>
        <name>Cravalho, Danielle</name>
      </author>
      <author>
        <name>Ryan-Shirey, Fiona</name>
      </author>
      <author>
        <name>Molina, Lisa</name>
      </author>
      <author>
        <name>Pemberton, Sarah Marie</name>
      </author>
      <author>
        <name>Cheney, Ann M</name>
        <uri>https://orcid.org/0000-0002-4032-6692</uri>
      </author>
    </item>
    <item>
      <title>Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia</title>
      <link>https://escholarship.org/uc/item/1101b7x5</link>
      <description>Oromandibular dystonia (OMD) is a form of focal dystonia that involves the masticatory, lower facial, labial, and lingual musculature. It is a disabling disorder which had limited treatment options until the recent introduction of botulinum toxin (BoNT) as the recommended first-line therapy by most experts and evidence-based literature. Owing to the complex relationship between the muscles of mastication and surrounding muscles, there is a wide variety of dynamic clinical presentations, making clinical recognition and the corresponding approach to BoNT injection therapy difficult. In this review, the authors provide a framework for practical clinical approaches, beginning with the recognition of clinical subtypes of OMD (jaw-opening, jaw-closing, jaw-deviating, lingual, &lt;i&gt;peri&lt;/i&gt;-oral, and/or pharyngeal dystonias), followed by patient selection and clinical evaluation to determine function interferences, with injection techniques illustrated for each subtype. Careful stepwise...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1101b7x5</guid>
      <pubDate>Mon, 21 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Bhidayasiri, Roongroj</name>
      </author>
      <author>
        <name>Maytharakcheep, Suppata</name>
      </author>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Neuropsychiatric Consequences of COVID-19 Pandemic: A Synthetic Review from a Global Perspective</title>
      <link>https://escholarship.org/uc/item/0fk0j5ns</link>
      <description>Some research suggests that distress, secondary to isolation and fear following COVID-19 infection, can negatively affect the long-term more than the COVID-19 infection itself. This narrative review aims to provide a global view on the neuropsychiatric consequences of COVID-19 that can be ascribed to several factors, ranging from the direct effect of infection, to the body's responses against the infection, or to the psychological sequelae of social isolation, unemployment, and fear for one's health and livelihood. Current findings show that the more severe the respiratory infection, the more likely are central nervous system (CNS) complications regarding the infection itself. The immune reactions to the infection may result in symptoms similar to chronic fatigue as well as neurocognitive deficits, which last long after the infection is gone. An increase in symptoms of depression, anxiety, and trauma-related stress may also follow upon economic fears and isolation from friends...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0fk0j5ns</guid>
      <pubDate>Fri, 11 Apr 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Pandi-Perumal, Seithikurippu R</name>
      </author>
      <author>
        <name>Somnogen Canada Inc, College Street</name>
      </author>
      <author>
        <name>Zaki, Nevin FW</name>
      </author>
      <author>
        <name>Qasim, Mohammad</name>
      </author>
      <author>
        <name>Morsy, Nesreen Elsayed</name>
      </author>
      <author>
        <name>Dilshad, Dilshad Md</name>
      </author>
      <author>
        <name>BaHammam, Ahmed S</name>
      </author>
      <author>
        <name>Jahrami, Haitham</name>
      </author>
      <author>
        <name>Ramasubramanian, Chellamuthu</name>
      </author>
      <author>
        <name>Karthikeyan, Ramanujam</name>
      </author>
      <author>
        <name>Supasitthumrong, Thitiporn</name>
      </author>
      <author>
        <name>Moscovitch, Adam</name>
      </author>
      <author>
        <name>Trakht, Ilya</name>
      </author>
      <author>
        <name>Gupta, Ravi</name>
      </author>
      <author>
        <name>Narasimhan, Meera</name>
      </author>
      <author>
        <name>Partonen, Timo</name>
      </author>
      <author>
        <name>Reiter, Russel J</name>
      </author>
      <author>
        <name>Morris, Gerwyn</name>
      </author>
      <author>
        <name>Berk, Michael</name>
      </author>
      <author>
        <name>Kennedy, Sidney H</name>
      </author>
      <author>
        <name>Stein, Dan J</name>
      </author>
      <author>
        <name>Stahl, Stephen M</name>
        <uri>https://orcid.org/0000-0002-6536-6973</uri>
      </author>
      <author>
        <name>Charney, Dennis S</name>
      </author>
      <author>
        <name>Seeman, Mary V</name>
      </author>
      <author>
        <name>Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences</name>
      </author>
      <author>
        <name>Sleep research unit, Department of Psychiatry</name>
      </author>
      <author>
        <name>Department of Psychiatry, North Area Armed Forces Hospital KSA</name>
      </author>
      <author>
        <name>Department of Rehabilitation Medicine, North Area-Armed Forces Hospital-KSA</name>
      </author>
      <author>
        <name>Department of Chest Medicine, Faculty of Medicine</name>
      </author>
      <author>
        <name>Department of Nursing, College of Applied Medical Sciences</name>
      </author>
      <author>
        <name>University Sleep Disorders Center, Department of Medicine</name>
      </author>
      <author>
        <name>Arabia, Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi</name>
      </author>
      <author>
        <name>College of Medicine and Medical Sciences, Arabian Gulf University</name>
      </author>
      <author>
        <name>Ministry of Health, Manama</name>
      </author>
      <author>
        <name>Division of Community Psychiatry, MS Chellamuthu Trust and Research Foundation</name>
      </author>
      <author>
        <name>Independent Researcher, Narayanapuram</name>
      </author>
      <author>
        <name>Department of Psychiatry, Chulalongkorn University Faculty of Medicine</name>
      </author>
      <author>
        <name>Department of Psychiatry, Faculty of Medicine</name>
      </author>
      <author>
        <name>Department of Medicine, Columbia University</name>
      </author>
      <author>
        <name>Department of Psychiatry, All India Institute of Medical Sciences</name>
      </author>
      <author>
        <name>Department of Neuropsychiatry and Behavioral Science, Columbia</name>
      </author>
      <author>
        <name>Department of Public Health and Welfare, Finnish Institute for Health and Welfare</name>
      </author>
      <author>
        <name>Department of Cell Systems and Anatomy, UT Health San Antonio</name>
      </author>
      <author>
        <name>The Institute for Mental and Physical Health and Clinical Translation Strategy Research Centre, Deakin University School of Medicine</name>
      </author>
      <author>
        <name>School of Public Health and Preventive Medicine, Monash University</name>
      </author>
      <author>
        <name>Department of Psychiatry, University of Melbourne</name>
      </author>
      <author>
        <name>Orygen Youth Health Research Centre, Parkville</name>
      </author>
      <author>
        <name>Department of Psychiatry, University of Toronto</name>
      </author>
      <author>
        <name>SAMRC Unit on Risk &amp; Resilience in Mental Disorders, Department of Psychiatry Neuroscience Institute</name>
      </author>
      <author>
        <name>Neuroscience Education Institute, University of California San Diego</name>
      </author>
      <author>
        <name>Departments of Psychiatry, Neuroscience</name>
      </author>
    </item>
    <item>
      <title>Differences in Long COVID severity by duration of illness, symptom evolution, and vaccination: a longitudinal cohort study from the INSPIRE group</title>
      <link>https://escholarship.org/uc/item/3rx1x07p</link>
      <description>Background: Although short-term outcomes of Long COVID have been described, longer-term physical and mental health outcomes of Long COVID are less well-established. This study sought to assess differences in long-term physical and mental health outcomes extending up to three years among those with current, resolved, and no Long COVID, as well as duration of Long COVID and vaccination status.
Methods: This was a prospective, multisite, study of participants with SARS-CoV-2 infection from 12/7/2020-8/29/2022, with data collected through 4/2/2024. Surveys included validated tools for physical and mental health. Data were analyzed by Long COVID status (never-had, resolved, current), Long COVID duration and vaccination status.
Findings: Of 3663 participants, 2604 (71.1%) never had Long COVID, 994 (27.1%) reported current Long COVID, and 65 (1.8%) reported resolved Long COVID. Compared to never having Long COVID, current Long COVID had lower/worse scores for Patient-Reported Outcomes...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3rx1x07p</guid>
      <pubDate>Mon, 31 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Gottlieb, Michael</name>
      </author>
      <author>
        <name>Yu, Huihui</name>
      </author>
      <author>
        <name>Chen, Ji</name>
      </author>
      <author>
        <name>Spatz, Erica S</name>
      </author>
      <author>
        <name>Gentile, Nicole L</name>
      </author>
      <author>
        <name>Geyer, Rachel E</name>
      </author>
      <author>
        <name>Santangelo, Michelle</name>
      </author>
      <author>
        <name>Malicki, Caitlin</name>
      </author>
      <author>
        <name>Gatling, Kristyn</name>
      </author>
      <author>
        <name>Saydah, Sharon</name>
      </author>
      <author>
        <name>O'Laughlin, Kelli N</name>
      </author>
      <author>
        <name>Stephens, Kari A</name>
      </author>
      <author>
        <name>Elmore, Joann G</name>
        <uri>https://orcid.org/0000-0002-7311-6835</uri>
      </author>
      <author>
        <name>Wisk, Lauren E</name>
        <uri>https://orcid.org/0000-0003-2932-4140</uri>
      </author>
      <author>
        <name>L'Hommedieu, Michelle</name>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Montoy, Juan Carlos C</name>
        <uri>https://orcid.org/0000-0001-7438-0243</uri>
      </author>
      <author>
        <name>Wang, Ralph C</name>
        <uri>https://orcid.org/0000-0001-5382-9486</uri>
      </author>
      <author>
        <name>Rising, Kristin L</name>
      </author>
      <author>
        <name>Kean, Efrat</name>
      </author>
      <author>
        <name>Dyal, Jonathan W</name>
      </author>
      <author>
        <name>Hill, Mandy J</name>
      </author>
      <author>
        <name>Venkatesh, Arjun K</name>
      </author>
      <author>
        <name>Weinstein, Robert A</name>
      </author>
    </item>
    <item>
      <title>Association of Race-Ethnicity Intersection With Disparities in Cigarette Smoking in U.S. Adults</title>
      <link>https://escholarship.org/uc/item/1w31b44v</link>
      <description>INTRODUCTION: Detailed estimates of disparities in cigarette smoking across single- and multi-race groups and their intersections with ethnicity are lacking. This study estimates the prevalence of self-reported current smoking among intersecting adult race-ethnicity groups in the United States.
AIMS AND METHODS: The analysis uses 2018-2019 data from the Tobacco Use Supplement-Current Population Supplement (TUS-CPS; n = 137 471). Self-reported Hispanic origin and race were recoded into 19 mutually exclusive race-by-ethnicity intersecting groups. Weighted race-ethnicity group smoking prevalence were compared to the overall population prevalence and one another.
RESULTS: Compared to the U.S. population current smoking prevalence (11.4% [95% CI = 11.2% to 11.6%]), smoking was particularly higher in non-Hispanic American Indian/Alaska Native (AI/AN) groups (20.7% [95% CI = 17.8% to 24.0%]) and non-Hispanic multiracial AI/AN/White (24.4% [95% CI = 20.3% to 29.1%]) and AI/AN/Black (22.4%...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1w31b44v</guid>
      <pubDate>Mon, 10 Mar 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Dai, Hongying Daisy</name>
      </author>
      <author>
        <name>Subica, Andrew</name>
        <uri>https://orcid.org/0000-0001-6424-7668</uri>
      </author>
      <author>
        <name>Mattingly, Delvon T</name>
      </author>
      <author>
        <name>Harlow, Alyssa</name>
      </author>
      <author>
        <name>Leventhal, Adam M</name>
      </author>
    </item>
    <item>
      <title>High-Value Care Education in the USA: Lessons from a National Value Curriculum for Resident and Fellow Physicians</title>
      <link>https://escholarship.org/uc/item/1hc2r5nq</link>
      <description>PurposePhysicians are estimated to be responsible for more than 50% of national healthcare costs and hold the greatest potential to improve value by orchestrating quality-driven programs to reduce unnecessary practices and variability. A physician’s ability to practice cost-conscious care has been linked to their training, underscoring the importance of integrating cost-conscious practice into training.MethodsThe High Value Practice Academic Alliance was formed to help advance the value-improvement work of individual institutions through a national organization. We developed a curriculum and mentorship model for trainees throughout the country titled the Future Leaders Program (FLP). Upon entry to FLP, GME physicians completed a baseline self-assessment of their knowledge about costs, payment, and value in healthcare. Over 1&amp;nbsp;year, these physicians participated in structured educational activities related to high-value care (HVC), received mentorship focused on leading a value-based...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1hc2r5nq</guid>
      <pubDate>Thu, 13 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Jain, Priya N</name>
      </author>
      <author>
        <name>King, Christopher J</name>
      </author>
      <author>
        <name>Johnson, Kiana</name>
      </author>
      <author>
        <name>Fogerty, Robert L</name>
      </author>
      <author>
        <name>Andukuri, Venkata G</name>
      </author>
      <author>
        <name>Thakur, Kshitij</name>
      </author>
      <author>
        <name>Popa, Remus</name>
      </author>
      <author>
        <name>Graves, Kencee K</name>
      </author>
    </item>
    <item>
      <title>The Provision and Utilization of Telehealth Within Academic Mental Health Clinics in North America During the COVID-19 Pandemic</title>
      <link>https://escholarship.org/uc/item/5sp525rx</link>
      <description>Objective: To document the experience of 14 academic child and adolescent psychiatry programs in transitioning to and managing telehealth services during the COVID-19 pandemic. The goal was to understand how programs adopted and sustained telehealth during the pandemic. Telehealth was defined as services delivered via videoconferencing and telephony.
Method: In this descriptive study, faculty from 14 programs completed online surveys about the use of both telehealth and in-person services from February 2020 to June 2021. Survey questions addressed telehealth practices (e.g., policies, support resources), monthly service utilization, telehealth modality (videoconferencing vs. telephony), and missed appointments.
Results: Programs varied in the proportion of appointments delivered by telehealth prior to the pandemic (February 2020; 0-27%). By May 2020 all programs were providing a majority of visits via telehealth (64-100%). In June 2021, all programs continued to provide services...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5sp525rx</guid>
      <pubDate>Tue, 4 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Oblath, Rachel</name>
      </author>
      <author>
        <name>Twohy, Eileen</name>
      </author>
      <author>
        <name>Higdon, Claudine</name>
      </author>
      <author>
        <name>Duncan, Alison</name>
      </author>
      <author>
        <name>Folk, Johanna B</name>
        <uri>https://orcid.org/0000-0003-0503-7307</uri>
      </author>
      <author>
        <name>Schiel, Marissa A</name>
      </author>
      <author>
        <name>Grewal, Seena</name>
      </author>
      <author>
        <name>Hawks, Jessica L</name>
      </author>
      <author>
        <name>Martinez, William</name>
        <uri>https://orcid.org/0000-0001-7821-1201</uri>
      </author>
      <author>
        <name>Coble, Kelly</name>
      </author>
      <author>
        <name>Edwards, Sarah</name>
      </author>
      <author>
        <name>Goetz, Amy</name>
      </author>
      <author>
        <name>Ramtekkar, Ujjwal</name>
      </author>
      <author>
        <name>Kulkarni, Chetana A</name>
      </author>
      <author>
        <name>Khan, Shabana</name>
      </author>
      <author>
        <name>Doan, Bridget T</name>
      </author>
      <author>
        <name>Nallapula, Kishan</name>
      </author>
      <author>
        <name>Fornari, Victor</name>
      </author>
      <author>
        <name>Fortuna, Lisa R</name>
        <uri>https://orcid.org/0000-0002-5336-4970</uri>
      </author>
      <author>
        <name>Myers, Kathleen</name>
      </author>
    </item>
    <item>
      <title>Eye movement abnormalities in movement disorders</title>
      <link>https://escholarship.org/uc/item/8sr67126</link>
      <description>The visual system represents the most well-developed sensory system in humans, who are highly dependent on vision for organized response to their environment. The region of eye that is responsible for sharp central vision is the fovea. Thus, to see the world, images of objects of interest should fall on fovea. This is achieved through various sets of eye movements, all of which work together to keep the image of the target object on the fovea. It is therefore not surprising that a large part of the human brain is devoted to eye movements (e.g., several cortical and subcortical areas, including the brainstem, cerebellum and basal ganglia). Given that a large area of brain is devoted to eye movements, it is not surprising to find eye movement abnormalities in various brain disorders, including movement disorders. In fact, many of the movement disorders commonly encountered in clinical practice are associated with characteristic eye movement abnormalities that not only help in specific...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8sr67126</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Lal, Vivek</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Tardive dyskinesia versus tardive syndrome. What is in a name?</title>
      <link>https://escholarship.org/uc/item/8d96d2zr</link>
      <description>Tardive dyskinesia versus tardive syndrome. What is in a name?</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8d96d2zr</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Frei, Karen</name>
      </author>
      <author>
        <name>Scott, Alicia</name>
      </author>
      <author>
        <name>Caroff, Stanley N</name>
      </author>
      <author>
        <name>Jankovic, Joseph</name>
      </author>
      <author>
        <name>Ondo, William</name>
      </author>
      <author>
        <name>Citrome, Leslie</name>
      </author>
      <author>
        <name>Hauser, Robert</name>
      </author>
      <author>
        <name>Friedman, Joseph H</name>
      </author>
      <author>
        <name>Bhidayasiri, Roongroj</name>
      </author>
      <author>
        <name>Sajatovic, Martha</name>
      </author>
      <author>
        <name>Alters, Dennis</name>
      </author>
      <author>
        <name>Meyer, Jonathan</name>
        <uri>https://orcid.org/0000-0001-7294-4834</uri>
      </author>
      <author>
        <name>Factor, Stuart</name>
      </author>
      <author>
        <name>Tan, EK</name>
      </author>
      <author>
        <name>Remington, G</name>
      </author>
      <author>
        <name>Glick, Ira</name>
      </author>
      <author>
        <name>Fernandez, Hubert</name>
      </author>
      <author>
        <name>Comella, Cynthia</name>
      </author>
      <author>
        <name>Kane, John</name>
      </author>
      <author>
        <name>McEvoy, Joseph</name>
      </author>
      <author>
        <name>Miller, Delwyn</name>
      </author>
      <author>
        <name>Zai, Clement C</name>
      </author>
      <author>
        <name>Lindenmayer, JP</name>
      </author>
      <author>
        <name>Trosch, Richard</name>
      </author>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Cervical dystonia: Injecting botulinum neurotoxin into semispinalis capitis improves goose-neck posture</title>
      <link>https://escholarship.org/uc/item/50f621sx</link>
      <description>We describe a patient with goose-neck posture as the presenting form of cervical dystonia. In our case, the bilateral semispinalis capitis muscles were hypertrophic, thick, and overactive while both splenius capitis and sternocleidomastoid muscles were normal. In this single case experience, we demonstrated that the semispinalis capitis muscle may play a primary role in causing a goose-neck posture and the observed forward sagittal shift may be a compensatory or overflow activity of neck flexor muscles. Therefore, botulinum toxin injection to the semispinalis capitis muscles can be considered in the management of patients with goose-neck posture.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/50f621sx</guid>
      <pubDate>Mon, 3 Feb 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Tran, Tai Ngoc</name>
      </author>
      <author>
        <name>Le, Minh</name>
      </author>
      <author>
        <name>Dang, Thuong Huyen Thi</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>The Impact of a Caregiver’s Chronic Illness on Childhood Psychosocial Functioning</title>
      <link>https://escholarship.org/uc/item/9w3417c8</link>
      <description>INTRODUCTION: Prolonged activation of the body's stress response from chronic exposure to adverse stressors may have a significant impact on lifelong psychosocial functioning. Screening for the impact of prolonged adversity in childhood has become an integral component of pediatric care. While past research has separately explored the impact of caregiver chronic illness and caregiver toxic stress on children, the relationship between caregiver chronic illness disability burden, caregiver parental toxic stress, and their child's psychosocial functioning is not well understood. This study aimed to investigate how caregiver chronic illness disability burden and caregiver toxic stress impact childhood psychosocial dysfunction (CPD).
METHOD: This pilot study was conducted at two free family medicine clinics in Inland Southern California between August and December 2022. It surveyed caregivers with chronic illness of any age or functional capacity who are full-time caretakers of children...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9w3417c8</guid>
      <pubDate>Thu, 30 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Banihani, Shamieh</name>
        <uri>https://orcid.org/0000-0003-4889-7710</uri>
      </author>
      <author>
        <name>Zimmer, Samantha</name>
      </author>
      <author>
        <name>Tagvoryan, Annie</name>
      </author>
      <author>
        <name>Setaghiyan, Helen</name>
      </author>
      <author>
        <name>Novak, Daniel</name>
      </author>
      <author>
        <name>Osei, Adwoa</name>
      </author>
    </item>
    <item>
      <title>Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease</title>
      <link>https://escholarship.org/uc/item/9q8019sb</link>
      <description>An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9q8019sb</guid>
      <pubDate>Sat, 25 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Elmer, Lawrence W</name>
      </author>
      <author>
        <name>Juncos, Jorge L</name>
      </author>
      <author>
        <name>Singer, Carlos</name>
      </author>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Criswell, Susan R</name>
      </author>
      <author>
        <name>Parashos, Sotirios</name>
      </author>
      <author>
        <name>Felt, Larissa</name>
      </author>
      <author>
        <name>Johnson, Reed</name>
      </author>
      <author>
        <name>Patni, Rajiv</name>
      </author>
    </item>
    <item>
      <title>Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study</title>
      <link>https://escholarship.org/uc/item/5267x8tg</link>
      <description>BACKGROUND: Injectable daxibotulinumtoxinA (an investigational botulinum toxin, RT002) may offer a more prolonged duration of response-and therefore less frequent dosing-than onabotulinumtoxinA.
OBJECTIVES: To perform a phase 2, open-label, dose-escalation study to assess the efficacy and safety of daxibotulinumtoxinA in cervical dystonia.
METHODS: Subjects with moderate-to-severe isolated cervical dystonia were enrolled in sequential cohorts to receive a single open-label, intramuscular dose of injectable daxibotulinumtoxinA of up to 200 U (&lt;i&gt;n =&lt;/i&gt; 12), 200-300 U (&lt;i&gt;n =&lt;/i&gt; 12), or 300-450 U (&lt;i&gt;n =&lt;/i&gt; 13; https://clinicaltrials.gov identifier NCT02706795).
RESULTS: Overall, 33/37 enrollees completed the trial. DaxibotulinumtoxinA was associated with mean reductions in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)-Total score of 16.8 (38%) at week 4, 21.3 (50%) at week 6, and 12.8 (30%) at week 24. The proportion of subjects who were responders (achieved ≥...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5267x8tg</guid>
      <pubDate>Sat, 25 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Jankovic, Joseph</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Patel, Atul T</name>
      </author>
      <author>
        <name>Brashear, Allison</name>
      </author>
      <author>
        <name>Evatt, Marian</name>
      </author>
      <author>
        <name>Rubio, Roman G</name>
      </author>
      <author>
        <name>Oh, Chad K</name>
      </author>
      <author>
        <name>Snyder, Daniel</name>
      </author>
      <author>
        <name>Shears, Gill</name>
      </author>
      <author>
        <name>Comella, Cynthia</name>
      </author>
    </item>
    <item>
      <title>Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease</title>
      <link>https://escholarship.org/uc/item/3f40p5bv</link>
      <description>BackgroundAlthough levodopa is considered the most effective pharmacotherapy for motor symptoms of Parkinson’s disease (PD), chronic use is associated with motor complications, including fluctuating response and unpredictable, involuntary movements called dyskinesia. ADS-5102 (amantadine) extended-release (ER) capsules (GOCOVRITM) is a recent US FDA-approved treatment for dyskinesia in PD patients. ADS-5102 is a high-dose, ER formulation of amantadine, administered orally once daily at bedtime, that achieves high plasma drug concentrations throughout the day.ObjectiveIn this study, we present pooled results from two randomized, double-blind, placebo-controlled, phase III ADS-5102 trials.Patients and MethodsThe two studies in PD patients with dyskinesia shared design and eligibility criteria, differing only in treatment duration. Results from common assessment time points were pooled.ResultsAt 12&amp;nbsp;weeks, the least squares (LS) mean change in total score on the Unified Dyskinesia...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3f40p5bv</guid>
      <pubDate>Sat, 25 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Elmer, Lawrence W</name>
      </author>
      <author>
        <name>Juncos, Jorge L</name>
      </author>
      <author>
        <name>Singer, Carlos</name>
      </author>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Criswell, Susan R</name>
      </author>
      <author>
        <name>Parashos, Sotirios</name>
      </author>
      <author>
        <name>Felt, Larissa</name>
      </author>
      <author>
        <name>Johnson, Reed</name>
      </author>
      <author>
        <name>Patni, Rajiv</name>
      </author>
    </item>
    <item>
      <title>Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort.</title>
      <link>https://escholarship.org/uc/item/28t5z3s2</link>
      <description>OBJECTIVE: To assess the clinical manifestations and predictors of different types of tremors in individuals with different types of isolated dystonia.
METHODS: Clinical manifestations of tremor were assessed in a multicenter, international cross-sectional, cohort study of 2,362 individuals with all types of isolated dystonia (focal, segmental, multifocal, and generalized) recruited through the Dystonia Coalition.
RESULTS: Methodical and standardized assessments of all participants in this cohort revealed the overall prevalence of any type of tremor was 53.3%. The prevalence of dystonic tremor varied from 36.9% to 48.4%, depending on criteria used to define it. To identify the factors associated with tremors in dystonia, the data were analyzed by generalized linear modeling and cluster analyses. Generalized linear modeling indicated 2 of the strongest factors associated with tremor included body region affected by dystonia and recruitment center. Tremor was also associated with...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/28t5z3s2</guid>
      <pubDate>Fri, 24 Jan 2025 00:00:00 +0000</pubDate>
      <author>
        <name>Shaikh, Aasef G</name>
      </author>
      <author>
        <name>Beylergil, Sinem Balta</name>
      </author>
      <author>
        <name>Scorr, Laura</name>
      </author>
      <author>
        <name>Kilic-Berkmen, Gamze</name>
      </author>
      <author>
        <name>Freeman, Alan</name>
      </author>
      <author>
        <name>Klein, Christine</name>
      </author>
      <author>
        <name>Junker, Johanna</name>
      </author>
      <author>
        <name>Loens, Sebastian</name>
      </author>
      <author>
        <name>Brüggemann, Norbert</name>
      </author>
      <author>
        <name>Münchau, Alexander</name>
      </author>
      <author>
        <name>Bäumer, Tobias</name>
      </author>
      <author>
        <name>Vidailhet, Marie</name>
      </author>
      <author>
        <name>Roze, Emmanuel</name>
      </author>
      <author>
        <name>Bonnet, Cecilia</name>
      </author>
      <author>
        <name>Jankovic, Joseph</name>
      </author>
      <author>
        <name>Jimenez-Shahed, Joohi</name>
      </author>
      <author>
        <name>Patel, Neepa</name>
      </author>
      <author>
        <name>Marsh, Laura</name>
      </author>
      <author>
        <name>Comella, Cynthia</name>
      </author>
      <author>
        <name>Barbano, Richard L</name>
      </author>
      <author>
        <name>Berman, Brian D</name>
      </author>
      <author>
        <name>Malaty, Irene</name>
      </author>
      <author>
        <name>Wagle Shukla, Aparna</name>
      </author>
      <author>
        <name>Reich, Stephen G</name>
      </author>
      <author>
        <name>Ledoux, Mark S</name>
      </author>
      <author>
        <name>Berardelli, Alfredo</name>
      </author>
      <author>
        <name>Ferrazzano, Gina</name>
      </author>
      <author>
        <name>Stover, Natividad</name>
      </author>
      <author>
        <name>Ondo, William</name>
      </author>
      <author>
        <name>Pirio Richardson, Sarah</name>
      </author>
      <author>
        <name>Saunders-Pullman, Rachel</name>
      </author>
      <author>
        <name>Mari, Zoltan</name>
      </author>
      <author>
        <name>Agarwal, Pinky</name>
      </author>
      <author>
        <name>Adler, Charles</name>
      </author>
      <author>
        <name>Chouinard, Sylvain</name>
      </author>
      <author>
        <name>Fox, Susan H</name>
      </author>
      <author>
        <name>Brashear, Allison</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Suchowersky, Oksana</name>
      </author>
      <author>
        <name>Frank, Samuel</name>
      </author>
      <author>
        <name>Factor, Stewart</name>
      </author>
      <author>
        <name>Perlmutter, Joel</name>
      </author>
      <author>
        <name>Jinnah, Hyder Azad</name>
      </author>
    </item>
    <item>
      <title>Exploring Youths’ Offers to Use E-Cigarettes in Rural Hawai‘i: A Test Development and Validation Study</title>
      <link>https://escholarship.org/uc/item/6st4p1rz</link>
      <description>The purpose of this study is to describe the development and initial validation of a survey focused on problematic situations involving e-cigarette use by rural Native Hawaiian and Pacific Islander (NHPI) youths. A 5-phase approach to test development and validation was used. In Phase 1 (Item Generation), survey items were created from a series of focus groups with middle school youths on Hawai'i Island (&lt;i&gt;N&lt;/i&gt; = 69). In Phase 2 (Item Refinement and Selection), situational items were reduced to 40 e-cigarette offer situations that were selected for inclusion in the survey. In Phase 3 (Item Reduction), items were administered to 257 youths from 11 middle, intermediate, or multi-level public or public-charter schools on Hawai'i Island. Exploratory factor analysis indicated the presence of three factors accounting for 50% of the variance: E-Cigarette Offers from Friends (24%), E-Cigarette Offers from Non-Friends (16%), and Coercive Pressure to Use E-Cigarettes (10%). Hypothesized...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6st4p1rz</guid>
      <pubDate>Mon, 9 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Okamoto, Scott K</name>
      </author>
      <author>
        <name>Subica, Andrew M</name>
        <uri>https://orcid.org/0000-0001-6424-7668</uri>
      </author>
      <author>
        <name>Okamura, Kelsie H</name>
      </author>
      <author>
        <name>An, Katlyn J</name>
      </author>
      <author>
        <name>Song, Sarah D</name>
      </author>
      <author>
        <name>Saladino, Paula Angela</name>
      </author>
      <author>
        <name>Carson, Adabelle B</name>
      </author>
      <author>
        <name>Kon, Zarek K</name>
      </author>
      <author>
        <name>Marshall, Sarah Momilani</name>
      </author>
      <author>
        <name>Chin, Steven Keone</name>
      </author>
      <author>
        <name>Kaholokula, Joseph Keawe aimoku</name>
      </author>
      <author>
        <name>Pagano, Ian</name>
      </author>
      <author>
        <name>Pokhrel, Pallav</name>
      </author>
    </item>
    <item>
      <title>Predictive modeling of spread in adult‐onset isolated dystonia: Key properties and effect of tremor inclusion</title>
      <link>https://escholarship.org/uc/item/0b37f8r1</link>
      <description>BACKGROUND AND PURPOSE: Several clinical and demographic factors relate to anatomic spread of adult-onset isolated dystonia, but a predictive model is still lacking. The aims of this study were: (i) to develop and validate a predictive model of anatomic spread of adult-onset isolated dystonia; and (ii) to evaluate whether presence of tremor associated with dystonia influences model predictions of spread.
METHODS: Adult-onset isolated dystonia participants with focal onset from the Dystonia Coalition Natural History Project database were included. We developed two prediction models, one with dystonia as sole disease manifestation ("dystonia-only") and one accepting dystonia OR tremor in any body part as disease manifestations ("dystonia OR tremor"). Demographic and clinical predictors were selected based on previous evidence, clinical plausibility of association with spread, or both. We used logistic regressions and evaluated model discrimination and calibration. Internal validation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0b37f8r1</guid>
      <pubDate>Mon, 2 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Meng</name>
      </author>
      <author>
        <name>Sajobi, Tolulope</name>
      </author>
      <author>
        <name>Morgante, Francesca</name>
      </author>
      <author>
        <name>Adler, Charles</name>
      </author>
      <author>
        <name>Agarwal, Pinky</name>
      </author>
      <author>
        <name>Bäumer, Tobias</name>
      </author>
      <author>
        <name>Berardelli, Alfredo</name>
      </author>
      <author>
        <name>Berman, Brian D</name>
      </author>
      <author>
        <name>Blumin, Joel</name>
      </author>
      <author>
        <name>Borsche, Max</name>
      </author>
      <author>
        <name>Brashear, Allison</name>
      </author>
      <author>
        <name>Deik, Andres</name>
      </author>
      <author>
        <name>Duque, Kevin</name>
      </author>
      <author>
        <name>Espay, Alberto J</name>
      </author>
      <author>
        <name>Ferrazzano, Gina</name>
      </author>
      <author>
        <name>Feuerstein, Jeanne</name>
      </author>
      <author>
        <name>Fox, Susan</name>
      </author>
      <author>
        <name>Frank, Samuel</name>
      </author>
      <author>
        <name>Hallett, Mark</name>
      </author>
      <author>
        <name>Jankovic, Joseph</name>
      </author>
      <author>
        <name>LeDoux, Mark S</name>
      </author>
      <author>
        <name>Leegwater‐Kim, Julie</name>
      </author>
      <author>
        <name>Mahajan, Abhimanyu</name>
      </author>
      <author>
        <name>Malaty, Irene A</name>
      </author>
      <author>
        <name>Ondo, William</name>
      </author>
      <author>
        <name>Pantelyat, Alexander</name>
      </author>
      <author>
        <name>Pirio‐Richardson, Sarah</name>
      </author>
      <author>
        <name>Roze, Emmanuel</name>
      </author>
      <author>
        <name>Saunders‐Pullman, Rachel</name>
      </author>
      <author>
        <name>Suchowersky, Oksana</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Vidailhet, Marie</name>
      </author>
      <author>
        <name>Shukla, Aparna Wagle</name>
      </author>
      <author>
        <name>Perlmutter, Joel S</name>
      </author>
      <author>
        <name>Jinnah, Hyder A</name>
      </author>
      <author>
        <name>Martino, Davide</name>
      </author>
    </item>
    <item>
      <title>Diffuse Lewy body disease</title>
      <link>https://escholarship.org/uc/item/8gz9d76w</link>
      <description>Diffuse Lewy body disease, also called dementia with Lewy bodies (DLB), is defined as progressive dementia and pathological Lewy bodies distributed in the central and autonomic nervous systems. The clinical features are dementia, cognitive fluctuations, visual hallucinations, parkinsonism, and REM sleep behavior disorder (RBD). Confirmatory techniques include dopamine transporter imaging, meta-iodobenzylguanidine (MIBG) myocardial scintigraphy, and polysomnography. The pathology finding in DLB is misfolded alpha-synuclein, the main component of Lewy bodies, propagating in the central nervous system. This may interrupt the acetylcholine pathway and activate an inflammatory response. Mutations of several genes have been found in patients with DLB, including SNCA, GBA, and APOE. The differential diagnosis of DLB and Parkinson's disease with dementia (PDD) is a debated issue. Clinical features distinguishing DLB from PDD include the timing of dementia and visual hallucinations, responses...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8gz9d76w</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lin, Yu Wei</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>The effect of Non-Motor symptoms on Health-Related quality of life in patients with young onset Parkinson’s Disease: A single center Vietnamese Cross-Sectional study</title>
      <link>https://escholarship.org/uc/item/7vp082q1</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;Young onset Parkinson's disease (YOPD) is a distinct entity from typical late onset Parkinson's disease (LOPD). The influene of non-motor features on the health - related quality of life (HRQoL) in LOPD has been previously reported, but little is known about the impact of non-motor features in YOPD.&lt;h4&gt;Objective&lt;/h4&gt;The aim of this study was to explore the relationship between non-motor burden and HRQoL in patients with YOPD.&lt;h4&gt;Methods&lt;/h4&gt;This was an observational, cross-sectional study in patients with a PD, whose age at disease onset ranged from 21 to 40&amp;nbsp;years (YOPD). Participants were assessed with the MDS Unified Parkinson's Disease Rating Scale (MDS-UPDRS), Non-Motor Symptoms Scale (NMSS) and the 39-item Parkinson's Disease Questionnaire (PDQ-39; range 0-100). Spearman's rank test was used to identify correlations between NMSS domains and several dimension of HRQoL. Stepwise multiple linear regression analysis was performed to identify the independent...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/7vp082q1</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Tran, Tai Ngoc</name>
      </author>
      <author>
        <name>Le Ha, Uyen Ngoc</name>
      </author>
      <author>
        <name>Nguyen, Tuan Manh</name>
      </author>
      <author>
        <name>Nguyen, Thuan Duc</name>
      </author>
      <author>
        <name>Vo, Khang Ngoc Chung</name>
      </author>
      <author>
        <name>Dang, Thuong Huyen</name>
      </author>
      <author>
        <name>Trinh, Paula Mai Phuong</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>The nosology of tardive syndromes</title>
      <link>https://escholarship.org/uc/item/71p8z8wk</link>
      <description>Since the original description of side effects of neuroleptics, different terminologies and definitions for tardive dyskinesia (TD) and tardive syndrome (TS) have been used by different authors, and often these two terms have been used interchangeably. This paper proposes a nosology designed to define and clarify various terms and phenomenologies within the TS spectrum. We propose to use the term tardive dyskinesia to refer to the original description of repetitive and complex oral-buccal-lingual (OBL) movements, as well as to the analogous repetitive movements that can appear in the limbs, trunk, or pelvis. The repetitive, relatively rhythmic nature of the movements is the common denominator of this phenomenologic category. The term tardive syndrome refers to the spectrum of all persistent hyperkinetic, hypokinetic and sensory phenomenologies resulting from chronic dopamine receptor blocking agents (DRBA) exposure. Thus, TS is an umbrella term. When dystonia is the main feature...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/71p8z8wk</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Frei, Karen</name>
      </author>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Fahn, Stanley</name>
      </author>
      <author>
        <name>Jankovic, Joseph</name>
      </author>
      <author>
        <name>Hauser, Robert A</name>
      </author>
    </item>
    <item>
      <title>The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations</title>
      <link>https://escholarship.org/uc/item/4xv673kz</link>
      <description>Silence information regulator 1 (SIRT1), a member of the sirtuin family, targets histones and many non-histone proteins and participates in various physiological functions. The enzymatic activity of SIRT1 is decreased in patients with Parkinson's disease (PD), which may reduce their ability to resist neuronal damage caused by various neurotoxins. As far as we know, SIRT1 can induce autophagy by regulating autophagy related proteins such as AMP-activated protein kinase, light chain 3, mammalian target of rapamycin, and forkhead transcription factor 1. Furthermore, SIRT1 can regulate mitochondrial function and inhibit oxidative stress mainly by maintaining peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) in a deacetylated state and thus maintaining a constant level of PGC-1α. Other studies have demonstrated that SIRT1 may play a role in the pathophysiology of PD by regulating neuroinflammation. SIRT1 deacetylases nuclear factor-kappa B and thus reduces its transcriptional...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4xv673kz</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Li, Xuan</name>
      </author>
      <author>
        <name>Feng, Ya</name>
      </author>
      <author>
        <name>Wang, Xi-Xi</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Wu, Yun-Cheng</name>
      </author>
    </item>
    <item>
      <title>Prodromal Markers of Parkinson's Disease in Patients With Essential Tremor</title>
      <link>https://escholarship.org/uc/item/4s96v08j</link>
      <description>&lt;b&gt;Background:&lt;/b&gt; Essential tremor (ET) is manifested as an isolated syndrome of bilateral upper limb action tremor. Parkinson's disease (PD) is the second most common neurodegenerative disease, with typical motor symptoms of bradykinesia, rigidity, and resting tremor. ET-PD describes the new-onset of PD in ET patients. Recently, numerous studies on epidemiology, genetics, pathology, clinical features, and neuroimaging studies are challenging the idea that ET is an isolated disease, suggesting that patients with ET have the tendency to develop PD. &lt;b&gt;Methods:&lt;/b&gt; In this review article, we collected recent findings that reveal prodromal markers of PD in patients with ET. &lt;b&gt;Results:&lt;/b&gt; Substantia nigra hyperechogenicity serves as a prodromal marker for predicting the development of PD in patients with ET and provides a reference for therapeutic strategies. Additional potential markers include other neuroimaging, clinical features, heart rate, and genetics, whereas others lack...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4s96v08j</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Xi-Xi</name>
      </author>
      <author>
        <name>Feng, Ya</name>
      </author>
      <author>
        <name>Li, Xuan</name>
      </author>
      <author>
        <name>Zhu, Xiao-Ying</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Ondo, William G</name>
      </author>
      <author>
        <name>Wu, Yun-Cheng</name>
      </author>
    </item>
    <item>
      <title>Pain is common in early onset Parkinson's disease and pain severity is associated with age and worsening of motor and non-motor symptoms</title>
      <link>https://escholarship.org/uc/item/3805b0ct</link>
      <description>The consequences of pain in early onset Parkinson's disease (EOPD) remain under appreciated even though pain may exert an increasingly negative impact on patient quality of life as motor and non-motor symptoms worsen. In this prospective study, we investigate the prevalence and severity of pain in 135 Vietnamese patients with EOPD from three medical centers using the King's PD Pain Scale (KPPS), the Mini Mental Status Exam (MMSE), the Unified Parkinson's Disease Rating Scale (UPDRS) and the Non-Motor Symptoms Scale (NMSS). Pain was reported by 79.3%. The most common subtype of pain was musculoskeletal (70.1%), followed by nocturnal (43.9%), radicular (43.0%), chronic (42.1%), fluctuation-related (34.6%) and orofacial pain (16.8%). Most patients (74.8%) experienced more than one pain subtype. Fluctuation-related pain and orofacial pain were significantly more prevalent among patients with higher Hoehn &amp;amp; Yahr (H&amp;amp;Y) stages (3-5) versus lower H&amp;amp;Y stages (1-2). Pain subtype...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3805b0ct</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hoang, Dung Thi</name>
      </author>
      <author>
        <name>Xing, Frank</name>
      </author>
      <author>
        <name>Nguyen, Thuan Duc</name>
      </author>
      <author>
        <name>Nguyen, Ton Dang</name>
      </author>
      <author>
        <name>Tran, Tai Ngoc</name>
      </author>
      <author>
        <name>Nhu, Son Dinh</name>
      </author>
      <author>
        <name>Nguyen, Quang Huu</name>
      </author>
      <author>
        <name>Nguyen, Hai Thanh</name>
      </author>
      <author>
        <name>Hoang, Ung Tien</name>
      </author>
      <author>
        <name>Than, Quyen Van</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.</title>
      <link>https://escholarship.org/uc/item/30q0z0rt</link>
      <description>BACKGROUND: Parkinson disease (PD) is associated with α-synuclein (αS) aggregation within enteric neurons. ENT-01 inhibits the formation of αS aggregates and improved constipation in an open-label study in patients with PD.
OBJECTIVE: To evaluate the safety and efficacy of oral ENT-01 for constipation and neurologic symptoms in patients with PD and constipation.
DESIGN: Randomized, placebo-controlled phase 2b study. (ClinicalTrials.gov: NCT03781791).
SETTING: Outpatient.
PATIENTS: 150 patients with PD and constipation.
INTERVENTION: ENT-01 or placebo daily for up to 25 days. After baseline assessment of constipation severity, daily dosing was escalated to the prokinetic dose, the maximum dose (250 mg), or the tolerability limit, followed by a washout period.
MEASUREMENTS: The primary efficacy end point was the number of complete spontaneous bowel movements (CSBMs) per week. Neurologic end points included dementia (assessed using the Mini-Mental State Examination [MMSE]) and psychosis...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/30q0z0rt</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Camilleri, Michael</name>
      </author>
      <author>
        <name>Subramanian, Thyagarajan</name>
      </author>
      <author>
        <name>Pagan, Fernando</name>
      </author>
      <author>
        <name>Isaacson, Stuart</name>
      </author>
      <author>
        <name>Gil, Ramon</name>
      </author>
      <author>
        <name>Hauser, Robert A</name>
      </author>
      <author>
        <name>Feldman, Mary</name>
      </author>
      <author>
        <name>Goldstein, Mark</name>
      </author>
      <author>
        <name>Kumar, Rajeev</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Chhabria, Nisha</name>
      </author>
      <author>
        <name>Walter, Benjamin L</name>
      </author>
      <author>
        <name>Eskenazi, Jonathan</name>
      </author>
      <author>
        <name>Riesenberg, Robert</name>
      </author>
      <author>
        <name>Burdick, Daniel</name>
      </author>
      <author>
        <name>Tse, Winona</name>
      </author>
      <author>
        <name>Molho, Eric</name>
      </author>
      <author>
        <name>Robottom, Bradley</name>
      </author>
      <author>
        <name>Bhatia, Perminder</name>
      </author>
      <author>
        <name>Kadimi, Srinath</name>
      </author>
      <author>
        <name>Klos, Kevin</name>
      </author>
      <author>
        <name>Shprecher, David</name>
      </author>
      <author>
        <name>Marquez-Mendoza, Otto</name>
      </author>
      <author>
        <name>Hidalgo, Gonzalo</name>
      </author>
      <author>
        <name>Grill, Stephen</name>
      </author>
      <author>
        <name>Li, George</name>
      </author>
      <author>
        <name>Mandell, Howard</name>
      </author>
      <author>
        <name>Hughes, Mary</name>
      </author>
      <author>
        <name>Stephenson, Sharisse</name>
      </author>
      <author>
        <name>Vandersluis, Joel</name>
      </author>
      <author>
        <name>Pfeffer, Michael</name>
      </author>
      <author>
        <name>Duker, Andrew</name>
      </author>
      <author>
        <name>Shivkumar, Vikram</name>
      </author>
      <author>
        <name>Kinney, William</name>
      </author>
      <author>
        <name>MacDougall, James</name>
      </author>
      <author>
        <name>Zasloff, Michael</name>
      </author>
      <author>
        <name>Barbut, Denise</name>
      </author>
    </item>
    <item>
      <title>Editorial: Tremors</title>
      <link>https://escholarship.org/uc/item/2tx2s8qj</link>
      <description>Editorial: Tremors</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2tx2s8qj</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Shaikh, Aasef</name>
      </author>
      <author>
        <name>Hallett, Mark</name>
      </author>
    </item>
    <item>
      <title>Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease</title>
      <link>https://escholarship.org/uc/item/2gp380k8</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;CVT-301 (Inbrija) is a self-administered orally inhaled levodopa approved for the intermittent treatment of OFF episodes in patients with Parkinson's disease (PD) treated with carbidopa/levodopa. Prior studies only evaluated CVT-301 after the first ON of the day.&lt;h4&gt;Objective and methods&lt;/h4&gt;The objective of this study was to evaluate the safety and tolerability of CVT-301 for early morning OFF. Using a randomized, double-blind, 2-way crossover design, eligible patients in the morning OFF state (having not received PD medication overnight) received a single dose of CVT-301 84&amp;nbsp;mg or placebo on 2 dosing days, immediately after their first morning oral carbidopa/levodopa dose. Safety assessments included treatment-emergent adverse events, vital signs, and patient- and examiner-reported dyskinesia. An exploratory efficacy assessment was examiner-rated time-to-ON with carbidopa/levodopa&amp;nbsp;+&amp;nbsp;CVT-301 vs carbidopa/levodopa&amp;nbsp;+&amp;nbsp;placebo.&lt;h4&gt;Results&lt;/h4&gt;Of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2gp380k8</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hauser, Robert A</name>
      </author>
      <author>
        <name>Isaacson, Stuart H</name>
      </author>
      <author>
        <name>Ellenbogen, Aaron</name>
      </author>
      <author>
        <name>Safirstein, Beth E</name>
      </author>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Komjathy, Steven F</name>
      </author>
      <author>
        <name>Kegler-Ebo, Deena M</name>
      </author>
      <author>
        <name>Zhao, Ping</name>
      </author>
      <author>
        <name>Oh, Charles</name>
      </author>
    </item>
    <item>
      <title>Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry</title>
      <link>https://escholarship.org/uc/item/2dz2c5dg</link>
      <description>BACKGROUND: The ANCHOR-CD prospective observational registry study evaluated the effectiveness of abobotulinumtoxinA in adult idiopathic cervical dystonia (CD) in clinical practice.
METHODS: Adults with CD were eligible. Treating physicians determined abobotulinumtoxinA dose and treatment interval. The primary endpoint was patient response rate (Toronto Western Spasmodic Torticollis Rating Scale [TWSTRS] score reduction≥25% and Patient Global Impression of Change [PGIC] score of +2 or +3 at Week 4 of Cycle 1).
RESULTS: 350 patients enrolled (75% women; mean age 59±13.6years; 27.4% botulinum neurotoxin-naive) and 347 received at least 1 treatment. The median abobotulinumtoxinA dose for Cycle 1 was 500 Units. At Week 4, the responder rate was 30.6% (n=304) and the TWSTRS total score decreased 27.4% from baseline. PGIC of at least "Much improved" was documented in 43.6% of patients and maintained in Cycles 2 through 4 (43.3%, 48.9%, and 52.8%, respectively). A total of 39 adverse...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2dz2c5dg</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Trosch, Richard M</name>
      </author>
      <author>
        <name>Espay, Alberto J</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Gil, Ramon</name>
      </author>
      <author>
        <name>Singer, Carlos</name>
      </author>
      <author>
        <name>LeWitt, Peter A</name>
      </author>
      <author>
        <name>Lew, Mark F</name>
      </author>
      <author>
        <name>Tagliati, Michele</name>
      </author>
      <author>
        <name>Adler, Charles H</name>
      </author>
      <author>
        <name>Chen, Jack J</name>
      </author>
      <author>
        <name>Marchese, Dominic</name>
      </author>
      <author>
        <name>Comella, Cynthia L</name>
      </author>
    </item>
    <item>
      <title>Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease</title>
      <link>https://escholarship.org/uc/item/2583r3xb</link>
      <description>&lt;h4&gt;Background&lt;/h4&gt;The Fist-Edge-Palm (FEP) test takes 0.5-3&amp;nbsp;min to complete and is highly sensitive in differentiating Alzheimer's disease and frontotemporal dementia from normal cognition, but it has not yet been studied in Parkinson's disease (PD).&lt;h4&gt;Objective&lt;/h4&gt;To determine the sensitivity and specificity of the FEP test in screening patients with PD for cognitive impairment and dementia.&lt;h4&gt;Methods&lt;/h4&gt;PD patients were recruited and divided into three groups based on cognitive status: normal cognition, mild cognitive impairment (MCI) and dementia according to 2015 MDS clinical diagnostic criteria for PD and clinical dementia rating scale (CDR) assessment for cognitive status. MMSE, FEP and clock drawing test (CDT) were tested in all recruited PD patients. Chi-square test was used to compare the sensitivity of FEP and CDT in detecting PDD and PD-MCI.&lt;h4&gt;Results&lt;/h4&gt;A total of 108 PD patients were included: 52 normal cognition, 28 MCI, and 28 dementia. The sensitivity...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2583r3xb</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Liu, Ye</name>
      </author>
      <author>
        <name>Qiu, Meng-Yao</name>
      </author>
      <author>
        <name>Zhang, Yu-Lei</name>
      </author>
      <author>
        <name>Zhang, Xiao-Jin</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Tan, Eng-King</name>
      </author>
      <author>
        <name>Wu, Yun-Cheng</name>
      </author>
    </item>
    <item>
      <title>Development and validation of the Vietnamese smell identification test</title>
      <link>https://escholarship.org/uc/item/0g0522f7</link>
      <description>BACKGROUND: Correct olfactory identification requires familiarity with the odor stimuli and is culturally dependent. Existing smell identification tests (SIT) are not culturally specific and may not be reliable in detecting hyposmia in all populations. This study aimed to develop a smell identification test suitable for Vietnamese patients (VSIT).
METHODS: The study included 4 phases: 1) survey-based evaluation of the familiarity of 68 odors to identify 18 odors for subsequent testing (N&amp;nbsp;=&amp;nbsp;1050); 2) smell identification test of 18 odors in healthy patients (N&amp;nbsp;=&amp;nbsp;50) to determine which 12 should be included in the VSIT; 3) comparison of VSIT scores on 12 odors in patients with hyposmia (N&amp;nbsp;=&amp;nbsp;60; Brief smell identification test (BSIT) score &amp;lt;8 and those with normosmia (N&amp;nbsp;=&amp;nbsp;120; BSIT score ≥8) to establish the validity of the newly developed test; and 4) retest of the VSIT in 60 normosmic patients from phase 3 (N&amp;nbsp;=&amp;nbsp;60) to determine...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0g0522f7</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Tran, Tai Ngoc</name>
      </author>
      <author>
        <name>Thi Dang, Thuong Huyen</name>
      </author>
      <author>
        <name>Thai, Truc Thanh</name>
      </author>
      <author>
        <name>Le, Hien Thi</name>
      </author>
      <author>
        <name>Nguyen, Thuy Thu Thi</name>
      </author>
      <author>
        <name>Nguyen, Hai Thi</name>
      </author>
      <author>
        <name>Nguyen, Anh Ngoc Thi</name>
      </author>
      <author>
        <name>Le Ha, Uyen Ngoc</name>
      </author>
      <author>
        <name>Vo, Khang Chung Ngoc</name>
      </author>
      <author>
        <name>Nguyen, Thanh Vinh</name>
      </author>
      <author>
        <name>van Nguyen, Thanh</name>
      </author>
      <author>
        <name>Ly, Quang Xuan</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Setting the record straight: The nosology of tardive syndromes</title>
      <link>https://escholarship.org/uc/item/0782w4tv</link>
      <description>We propose the use of the term tardive dyskinesia to refer to the original description of repetitive and complex oral-buccal-lingual (OBL) movements and the analogous repetitive movements of the limbs, trunk, or pelvis. The term tardive syndrome is an umbrella term to be used to refer to the spectrum of all persistent hyperkinetic, hypokinetic, and sensory phenomenologies resulting from chronic dopamine receptor blocking agent (DRBA) exposure. TD is a type of TS. The term tardive dystonia (TDyst) should be used when dystonia is the main feature of TS. Retrocollis and oromandibular dystonia appear to be the most common form of Tdyst. Tardive akathisia refers to the inability to remain still with an urge to move, giving the appearance of restlessness. In tardive tourettism, the patient has complex motor and phonic tics associated with premonitory urge and relief of tension after performing the tic behavior, thus resembling Tourette's syndrome. Tardive tremor is composed of mainly...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0782w4tv</guid>
      <pubDate>Sun, 1 Dec 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Frei, Karen</name>
      </author>
    </item>
    <item>
      <title>COVID-19 vaccine booster willingness among Asian Americans: Influence of racial discrimination and social determinants</title>
      <link>https://escholarship.org/uc/item/806758gd</link>
      <description>Uptake of COVID-19 vaccine booster doses is an important public health topic of study to prevent morbidity and mortality in underserved U.S. populations. However, limited research exists on COVID-19 vaccine booster use and willingness - including its associated factors - among Asian Americans (AA): the fastest growing racial group in the U.S. This study collected survey data from 447 AA adults from three large AA subgroups: Chinese, Korean, and Filipino. Data were collected as part of a community-driven county-wide needs assessment conducted in collaboration with AA community organizations in Riverside County, California. Data indicated that nearly 24% of AA participants received at least four doses of the COVID-19 vaccine, with 36% expressing definite willingness to receive future booster doses. Participants reported experiencing an average of 1.6 instances of racial discrimination across their lifetime. Ordered logistic regression and marginal effects analysis revealed ethnicity,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/806758gd</guid>
      <pubDate>Mon, 11 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Li, Qiuxi</name>
      </author>
      <author>
        <name>Subica, Andrew M</name>
        <uri>https://orcid.org/0000-0001-6424-7668</uri>
      </author>
    </item>
    <item>
      <title>Access to the internet and mobile applications in a mixed population emergency department: A repeated cross-sectional survey</title>
      <link>https://escholarship.org/uc/item/2qt4622h</link>
      <description>Objective: This study aimed to assess patients' interest in education content delivered through electronic modalities and identify trends in internet access and use among emergency department patients of various socioeconomic statuses.
Methods: A prospective, cross-sectional survey with 50 questions was completed by 241 English and Spanish-speaking patients in 2014 and repeated with 253 participants in 2019 at the University of California, Irvine Medical Center's Emergency Department (UCIMCED).
Results: Internet access increased from 83.8&amp;nbsp;% in 2014 to 88.1&amp;nbsp;% in 2019. Most internet-using patients owned smartphones (80.1&amp;nbsp;% in 2014, 89.7&amp;nbsp;% in 2019). Patients used electronic devices, such as fit bits and activity trackers, to obtain health information. Email was the preferred method for receiving discharge instructions.
Conclusions: As of 2019, 88.1&amp;nbsp;% of UCIMCED patients have access to the internet or email, making electronic media a reasonable venue for patient...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2qt4622h</guid>
      <pubDate>Thu, 7 Nov 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Toohey, Shannon</name>
      </author>
      <author>
        <name>Nguyen, Michelle T</name>
      </author>
      <author>
        <name>Saadat, Soheil</name>
        <uri>https://orcid.org/0000-0002-2744-7983</uri>
      </author>
      <author>
        <name>Chandwani, Carrie E</name>
      </author>
      <author>
        <name>Gassner, Stephen F</name>
      </author>
      <author>
        <name>Wray, Alisa</name>
      </author>
      <author>
        <name>Rivera, Ronald</name>
      </author>
      <author>
        <name>Wiechmann, Warren</name>
      </author>
    </item>
    <item>
      <title>Normative data for the Vietnamese smell identification test</title>
      <link>https://escholarship.org/uc/item/5383w94q</link>
      <description>Introduction: The 12-item Vietnamese smell identification test (VSIT) has been developed to evaluate the olfactory function of the Vietnamese population. This study aimed to investigate the normative value of the VSIT in different age groups and sexes.
Methods: This cross-sectional study was conducted at Ho Chi Minh University Medical Center, Vietnam. All participants were evaluated for odor identification ability using the VSIT.&amp;nbsp;We included healthy participants aged 18&amp;nbsp;years or older with no history of olfactory disturbances.
Results: A total of 391 healthy volunteers were recruited with a mean age of 45.80&amp;nbsp;years (SD: 17.62; range: 18-86; female: 63.4&amp;nbsp;%). The tenth percentile of scores on the 0-12 VSIT scale was 8.3 in participants aged 18-29&amp;nbsp;years, 9.0 in 30-39&amp;nbsp;years, 8.0 in 40-49&amp;nbsp;years, 7.8 in 50-59&amp;nbsp;years, 7.9 in 60-69&amp;nbsp;years and 6.0 in over 70&amp;nbsp;years. Young adults (18-39&amp;nbsp;years old) had better olfactory identification ability...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5383w94q</guid>
      <pubDate>Mon, 28 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Tran, Tai Ngoc</name>
      </author>
      <author>
        <name>Dang, Thuong Huyen Thi</name>
      </author>
      <author>
        <name>Thai, Truc Thanh</name>
      </author>
      <author>
        <name>Le Ngoc Ha, Uyen</name>
      </author>
      <author>
        <name>Le, Hien Thi</name>
      </author>
      <author>
        <name>Nguyen, Thuy Thu Thi</name>
      </author>
      <author>
        <name>Nguyen, Hai Thi</name>
      </author>
      <author>
        <name>Nguyen, Anh Ngoc Thi</name>
      </author>
      <author>
        <name>Vo, Khang Chung Ngoc</name>
      </author>
      <author>
        <name>Nguyen, Thanh Vinh</name>
      </author>
      <author>
        <name>van Nguyen, Thanh</name>
      </author>
      <author>
        <name>Ly, Quang Xuan</name>
      </author>
      <author>
        <name>Nguyen, Khang Vinh</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study</title>
      <link>https://escholarship.org/uc/item/23f8z68n</link>
      <description>IntroductionSome patients with cervical dystonia (CD) receiving long-term botulinum neurotoxin (BoNT) therapy report early waning of treatment benefit before the typical 12-week reinjection interval.&lt;h4&gt;Methods&lt;/h4&gt;This phase 4, open-label, randomized, noninferiority study (CD Flex; NCT01486264) compared 2 incobotulinumtoxinA injection schedules (Short Flex: 8&amp;nbsp;±&amp;nbsp;2&amp;nbsp;weeks; Long Flex: 14&amp;nbsp;±&amp;nbsp;2&amp;nbsp;weeks) in CD patients. Previous BoNT-responsive subjects who reported acceptable clinical benefit lasting&amp;nbsp;&amp;lt;&amp;nbsp;10&amp;nbsp;weeks were recruited. Efficacy and safety were evaluated after 8 injection cycles. The primary endpoint was change in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) severity subscale 4&amp;nbsp;weeks after the eighth injection. Secondary endpoints included TWSTRS total and subscale scores. Immunogenicity was assessed in a subset of patients.&lt;h4&gt;Results&lt;/h4&gt;Two hundred eighty-two CD patients were randomized and treated (Short Flex,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/23f8z68n</guid>
      <pubDate>Sun, 27 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Comella, Cynthia</name>
      </author>
      <author>
        <name>Hauser, Robert A</name>
      </author>
      <author>
        <name>Isaacson, Stuart H</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Oguh, Odinachi</name>
      </author>
      <author>
        <name>Hui, Jennifer</name>
      </author>
      <author>
        <name>Molho, Eric S</name>
      </author>
      <author>
        <name>Brodsky, Matthew</name>
      </author>
      <author>
        <name>Furr-Stimming, Erin</name>
      </author>
      <author>
        <name>Comes, Georg</name>
      </author>
      <author>
        <name>Hast, Michael A</name>
      </author>
      <author>
        <name>Charles, David</name>
      </author>
    </item>
    <item>
      <title>Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis</title>
      <link>https://escholarship.org/uc/item/6q108053</link>
      <description>&lt;h4&gt;Introduction&lt;/h4&gt;Parkinson's disease (PD) is associated with increased mortality risk (MR), reflecting progression of motor and nonmotor symptoms. PD psychosis (PDP), a common nonmotor symptom, increases with prolonged disease and elevates the MR of PD even further. Pimavanserin is the only FDA-approved treatment for PDP. This review summarizes real-world evidence around the MR of patients with PDP treated with pimavanserin versus off-label atypical antipsychotics.&lt;h4&gt;Methods&lt;/h4&gt;A PubMed search was conducted using the following search terms: &lt;i&gt;pimavanserin&lt;/i&gt; AND &lt;i&gt;antipsychotic&lt;/i&gt; AND &lt;i&gt;mortality&lt;/i&gt; AND &lt;i&gt;Parkinson's disease&lt;/i&gt; AND &lt;i&gt;psychosis&lt;/i&gt;. Inclusion criteria specified the entry of retrospective, observational, and open-label studies comparing pimavanserin to atypical antipsychotics or untreated controls.&lt;h4&gt;Results&lt;/h4&gt;A total of 10 of the 32 articles met inclusion criteria. Among five comparisons of pimavanserin with atypical antipsychotics, two were large...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6q108053</guid>
      <pubDate>Sat, 26 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Isaacson, Stuart H</name>
      </author>
      <author>
        <name>Pahwa, Rajesh</name>
      </author>
      <author>
        <name>Pagan, Fernando</name>
      </author>
      <author>
        <name>Abler, Victor</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Comparing smell identification ability among different motor subtypes of Parkinson’s disease using the Vietnamese Smell Identification Test and the Brief Smell Identification Test</title>
      <link>https://escholarship.org/uc/item/5r13p8f1</link>
      <description>Introduction: Olfactory dysfunction is one of the most common non-motor symptoms of Parkinson's disease (PD). The association between smell identification ability and motor subtypes of PD is not uniform in previous studies. This study aimed to compare the odor identification ability among different motor subtypes of PD in Vietnamese participants.
Methods: Patients who were diagnosed with PD according to the International Parkinson's Disease and Movement Disorder Society 2015 Diagnostic Criteria and had normal cognitive function were recruited. Participants were divided into akinetic-rigid (AR), tremor-dominant (TD), and mixed (MX) motor subgroups using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) score. Olfactory identification ability was evaluated using the Vietnamese Smell Identification Test (VSIT) and the Brief Smell Identification Test (BSIT). Cognitive status was assessed using the Mini-Mental State Examination (MMSE). Age, age at PD...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5r13p8f1</guid>
      <pubDate>Sat, 26 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Dang, Thuong Huyen Thi</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
      <author>
        <name>Nguyen, Khang Vinh</name>
      </author>
      <author>
        <name>Le Ngoc Ha, Uyen</name>
      </author>
      <author>
        <name>Vo, Khang Chung Ngoc</name>
      </author>
      <author>
        <name>Nguyen, Thanh Vinh</name>
      </author>
      <author>
        <name>Le, Hien Thi</name>
      </author>
      <author>
        <name>Tran, Tai Ngoc</name>
      </author>
    </item>
    <item>
      <title>Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm</title>
      <link>https://escholarship.org/uc/item/5dm2n6dz</link>
      <description>Multiple system atrophy (MSA) is a heterogenous condition, presenting with core clinical features of autonomic dysfunction, parkinsonism, and/or cerebellar ataxia. The presence of alpha-synuclein glial cytoplasmic inclusion is the hallmark of MSA. It shares a common pathological origin with Parkinson's disease (PD) and Lewy body dementia (DLB) and they are collectively grouped as "synucleinopathies." The pathological synuclein protein is now well- recognized in skin biopsies of these patients. Besides the pathological findings, radiological investigation is a useful diagnostic tool. Brain MRI helps rule out other etiologies, and findings like the "Hot-cross bun" sign, "putaminal atrophy," and "infratentorial findings" can assist with the diagnosis of MSA. Cardiac MIBG scan, autonomic testing, urodynamic studies can help differentiate MSA from other conditions. Although diagnostic tools are available for MSA diagnosis, clarity is needed on when to use these tests. We suggest a...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/5dm2n6dz</guid>
      <pubDate>Sat, 26 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Nandanwar, Deepmala</name>
      </author>
      <author>
        <name>Truong, Daniel D</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Diagnostic value of vietnamese smell identification test in Parkinson's disease</title>
      <link>https://escholarship.org/uc/item/03w2f76p</link>
      <description>&lt;h4&gt;Introduction&lt;/h4&gt;The Vietnamese Smell Identification Test (VSIT) has been validated in determining olfactory dysfunction in the Vietnamese population; however, its value in diagnosing Parkinson's disease (PD) has not been established.&lt;h4&gt;Methods&lt;/h4&gt;This case-control study was conducted at University Medical Center HCMC, Ho Chi Minh City, Vietnam. The study sample included non-demented PD patients and healthy controls (HC) who were gender- and age-matched. All participants were evaluated for odor identification ability using the VSIT and the Brief Smell Identification Test (BSIT).&lt;h4&gt;Results&lt;/h4&gt;A total of 218 HCs and 218 PD patients participated in the study. The median VSIT and BSIT scores were significantly different between PD and HC groups (VSIT, 5 (3) vs. 9 (2), P&amp;nbsp;&amp;lt;&amp;nbsp;0.0001; BSIT, 6 (3) vs 8 (2), P&amp;nbsp;&amp;lt;&amp;nbsp;0.0001). Using the cut-off of &amp;lt;8 for correct answers out of 12 odorants, the VSIT had higher sensitivity (84.4%) and specificity (86.2%) than...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/03w2f76p</guid>
      <pubDate>Sat, 26 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Dang, Thuong Huyen Thi</name>
      </author>
      <author>
        <name>Tran, Tai Ngoc</name>
      </author>
      <author>
        <name>Xing, Frank</name>
      </author>
      <author>
        <name>Ha, Uyen Le Ngoc</name>
      </author>
      <author>
        <name>Vo, Khang Chung Ngoc</name>
      </author>
      <author>
        <name>Nguyen, Thanh Vinh</name>
      </author>
      <author>
        <name>Nguyen, Khang Vinh</name>
      </author>
      <author>
        <name>Le, Hien Thi</name>
      </author>
      <author>
        <name>Truong, Daniel</name>
        <uri>https://orcid.org/0000-0001-6995-8936</uri>
      </author>
    </item>
    <item>
      <title>Long COVID Illness: Disparities in Understanding and Receipt of Care in Emergency Department Populations</title>
      <link>https://escholarship.org/uc/item/6b501043</link>
      <description>STUDY OBJECTIVE: Most long coronavirus disease (long COVID) studies rely on traditional surveillance methods that miss underserved populations who use emergency departments (EDs) as their primary health care source. In medically underserved ED populations, we sought to determine (1) whether there are gaps in awareness and self-declared understanding about long COVID illness, and (2) the prevalence, impact on school/work attendance, and receipt of care for long COVID symptoms.
METHODS: This study was a cross-sectional, convenience sample survey study of adult patients at 11 geographically representative US EDs from December 2022 to October 2023. Awareness and self-declared understanding about long COVID illness were measured. Prevalence, impact on school/work attendance, and receipt of care for long COVID symptoms were also assessed.
RESULTS: Of 1,618 eligible patients, 1455 (89.9%) agreed to participate, including 33.4% African Americans and 30.9% Latino/a. Of the patients, 17.1%...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6b501043</guid>
      <pubDate>Thu, 10 Oct 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Reyes, Karen</name>
      </author>
      <author>
        <name>Kumar, Vijaya Arun</name>
      </author>
      <author>
        <name>Chinnock, Brian</name>
      </author>
      <author>
        <name>Eucker, Stephanie A</name>
      </author>
      <author>
        <name>Rising, Kristin L</name>
      </author>
      <author>
        <name>Rafique, Zubaid</name>
      </author>
      <author>
        <name>Gottlieb, Michael</name>
      </author>
      <author>
        <name>Nichol, Graham</name>
      </author>
      <author>
        <name>Morse, Dana</name>
      </author>
      <author>
        <name>Molina, Melanie</name>
      </author>
      <author>
        <name>Arreguin, Mireya I</name>
      </author>
      <author>
        <name>Shughart, Lindsey</name>
      </author>
      <author>
        <name>Conn, Christopher</name>
      </author>
      <author>
        <name>Eckstrand, Svea</name>
      </author>
      <author>
        <name>Mesbah, Heba</name>
      </author>
      <author>
        <name>Chakraborty, Lauren</name>
      </author>
      <author>
        <name>Welch, Robert D</name>
      </author>
    </item>
    <item>
      <title>Naloxone and Patient Outcomes in Out-of-Hospital Cardiac Arrests in California</title>
      <link>https://escholarship.org/uc/item/83w8r76v</link>
      <description>Importance: The incidence of opioid-associated out-of-hospital cardiac arrest (OA-OHCA) has grown from less than 1% of OHCA in 2000 to between 7% and 14% of OHCA in recent years; American Heart Association (AHA) protocols suggest that emergency medical service (EMS) clinicians consider naloxone in OA-OHCA. However, it is unknown whether naloxone improves survival in these patients or in patients with undifferentiated OHCA.
Objective: To evaluate the association of naloxone with clinical outcomes in patients with undifferentiated OHCA.
Design, Setting, and Participants: Retrospective cohort study of EMS-treated patients aged 18 or older who received EMS treatment for nontraumatic OHCA in 3 Northern California counties between 2015 and 2023. Data were analyzed using propensity score-based models from February to April 2024.
Exposure: EMS administration of naloxone.
Main Outcomes and Measures: The primary outcome was survival to hospital discharge; the secondary outcome was sustained...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/83w8r76v</guid>
      <pubDate>Thu, 12 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Dillon, David G</name>
        <uri>https://orcid.org/0000-0003-0729-0162</uri>
      </author>
      <author>
        <name>Montoy, Juan Carlos C</name>
        <uri>https://orcid.org/0000-0001-7438-0243</uri>
      </author>
      <author>
        <name>Nishijima, Daniel K</name>
        <uri>https://orcid.org/0000-0003-4952-8212</uri>
      </author>
      <author>
        <name>Niederberger, Sara</name>
      </author>
      <author>
        <name>Menegazzi, James J</name>
      </author>
      <author>
        <name>Lacocque, Jeremy</name>
        <uri>https://orcid.org/0000-0003-2221-7705</uri>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Wang, Ralph C</name>
        <uri>https://orcid.org/0000-0001-5382-9486</uri>
      </author>
    </item>
    <item>
      <title>Protein-metabolite association studies identify novel proteomic determinants of metabolite levels in human plasma</title>
      <link>https://escholarship.org/uc/item/1n23b7sc</link>
      <description>Although many novel gene-metabolite and gene-protein associations have been identified using high-throughput biochemical profiling, systematic studies that leverage human genetics to illuminate causal relationships between circulating proteins and metabolites are lacking. Here, we performed protein-metabolite association studies in 3,626 plasma samples from three human cohorts. We detected 171,800 significant protein-metabolite pairwise correlations between 1,265 proteins and 365 metabolites, including established relationships in metabolic and signaling pathways such as the protein thyroxine-binding globulin and the metabolite thyroxine, as well as thousands of new findings. In Mendelian randomization (MR) analyses, we identified putative causal protein-to-metabolite associations. We experimentally validated top MR associations in proof-of-concept plasma metabolomics studies in three murine knockout strains of key protein regulators. These analyses identified previously unrecognized...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1n23b7sc</guid>
      <pubDate>Tue, 10 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Benson, Mark D</name>
      </author>
      <author>
        <name>Eisman, Aaron S</name>
      </author>
      <author>
        <name>Tahir, Usman A</name>
      </author>
      <author>
        <name>Katz, Daniel H</name>
      </author>
      <author>
        <name>Deng, Shuliang</name>
      </author>
      <author>
        <name>Ngo, Debby</name>
      </author>
      <author>
        <name>Robbins, Jeremy M</name>
      </author>
      <author>
        <name>Hofmann, Alissa</name>
      </author>
      <author>
        <name>Shi, Xu</name>
      </author>
      <author>
        <name>Zheng, Shuning</name>
      </author>
      <author>
        <name>Keyes, Michelle</name>
      </author>
      <author>
        <name>Yu, Zhi</name>
      </author>
      <author>
        <name>Gao, Yan</name>
      </author>
      <author>
        <name>Farrell, Laurie</name>
      </author>
      <author>
        <name>Shen, Dongxiao</name>
      </author>
      <author>
        <name>Chen, Zsu-Zsu</name>
      </author>
      <author>
        <name>Cruz, Daniel E</name>
      </author>
      <author>
        <name>Sims, Mario</name>
        <uri>https://orcid.org/0009-0006-4083-8328</uri>
      </author>
      <author>
        <name>Correa, Adolfo</name>
      </author>
      <author>
        <name>Tracy, Russell P</name>
      </author>
      <author>
        <name>Durda, Peter</name>
      </author>
      <author>
        <name>Taylor, Kent D</name>
      </author>
      <author>
        <name>Liu, Yongmei</name>
      </author>
      <author>
        <name>Johnson, W Craig</name>
      </author>
      <author>
        <name>Guo, Xiuqing</name>
      </author>
      <author>
        <name>Yao, Jie</name>
      </author>
      <author>
        <name>Chen, Yii-Der Ida</name>
      </author>
      <author>
        <name>Manichaikul, Ani W</name>
      </author>
      <author>
        <name>Jain, Deepti</name>
      </author>
      <author>
        <name>Yang, Qiong</name>
      </author>
      <author>
        <name>Consortium, NHLBI Trans-Omics for Precision Medicine</name>
      </author>
      <author>
        <name>Bouchard, Claude</name>
      </author>
      <author>
        <name>Sarzynski, Mark A</name>
      </author>
      <author>
        <name>Rich, Stephen S</name>
      </author>
      <author>
        <name>Rotter, Jerome I</name>
        <uri>https://orcid.org/0000-0001-7191-1723</uri>
      </author>
      <author>
        <name>Wang, Thomas J</name>
      </author>
      <author>
        <name>Wilson, James G</name>
      </author>
      <author>
        <name>Clish, Clary B</name>
      </author>
      <author>
        <name>Sarkar, Indra Neil</name>
      </author>
      <author>
        <name>Natarajan, Pradeep</name>
      </author>
      <author>
        <name>Gerszten, Robert E</name>
      </author>
    </item>
    <item>
      <title>Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group</title>
      <link>https://escholarship.org/uc/item/2xb9s6nh</link>
      <description>BACKGROUND: Long-term symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are a major concern, yet their prevalence is poorly understood.
METHODS: We conducted a prospective cohort study comparing adults with SARS-CoV-2 infection (coronavirus disease-positive [COVID+]) with adults who tested negative (COVID-), enrolled within 28 days of a Food and Drug Administration (FDA)-approved SARS-CoV-2 test result for active symptoms. Sociodemographic characteristics, symptoms of SARS-CoV-2 infection (assessed with the Centers for Disease Control and Prevention [CDC] Person Under Investigation Symptom List), and symptoms of post-infectious syndromes (ie, fatigue, sleep quality, muscle/joint pains, unrefreshing sleep, and dizziness/fainting, assessed with CDC Short Symptom Screener for myalgic encephalomyelitis/chronic fatigue syndrome) were assessed at baseline and 3 months via electronic surveys sent via text or email.
RESULTS: Among the first 1000...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2xb9s6nh</guid>
      <pubDate>Wed, 4 Sep 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Spatz, Erica S</name>
      </author>
      <author>
        <name>Gottlieb, Michael</name>
      </author>
      <author>
        <name>Wisk, Lauren E</name>
        <uri>https://orcid.org/0000-0003-2932-4140</uri>
      </author>
      <author>
        <name>Anderson, Jill</name>
      </author>
      <author>
        <name>Chang, Anna Marie</name>
      </author>
      <author>
        <name>Gentile, Nicole L</name>
      </author>
      <author>
        <name>Hill, Mandy J</name>
      </author>
      <author>
        <name>Huebinger, Ryan M</name>
      </author>
      <author>
        <name>Idris, Ahamed H</name>
      </author>
      <author>
        <name>Kinsman, Jeremiah</name>
      </author>
      <author>
        <name>Koo, Katherine</name>
      </author>
      <author>
        <name>Li, Shu-Xia</name>
      </author>
      <author>
        <name>McDonald, Samuel</name>
      </author>
      <author>
        <name>Plumb, Ian D</name>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Saydah, Sharon</name>
      </author>
      <author>
        <name>Slovis, Benjamin</name>
      </author>
      <author>
        <name>Stephens, Kari A</name>
      </author>
      <author>
        <name>Unger, Elizabeth R</name>
      </author>
      <author>
        <name>Wang, Ralph C</name>
        <uri>https://orcid.org/0000-0001-5382-9486</uri>
      </author>
      <author>
        <name>Yu, Huihui</name>
      </author>
      <author>
        <name>Hota, Bala</name>
      </author>
      <author>
        <name>Elmore, Joann G</name>
        <uri>https://orcid.org/0000-0002-7311-6835</uri>
      </author>
      <author>
        <name>Weinstein, Robert A</name>
      </author>
      <author>
        <name>Venkatesh, Arjun</name>
      </author>
    </item>
    <item>
      <title>Trauma and mental health in Pacific Islanders</title>
      <link>https://escholarship.org/uc/item/2nc8f30f</link>
      <description>BACKGROUND: Little is known about trauma and its mental health impact on Native Hawaiians/Pacific Islanders (NH/PI), an understudied Indigenous-colonized population that endures severe mental health disparities.
AIMS: This novel investigation assessed trauma prevalence and its mental health and substance use correlates in NH/PIs in the U.S.
METHOD: Using community-based participatory research methods, survey data on NH/PI trauma, depression, anxiety, substance use, and treatment need were collected from 306 NH/PI adults using online, telephone, and in-person methods. Descriptive statistics and adjusted regression models were employed.
RESULTS: Sixty-nine percent of participants experienced lifetime trauma, reporting mean exposure to 2.5 different trauma types. Childhood physical and sexual abuse, and lifetime forced sexual assault rates were 34%, 25%, and 27%, respectively, exceeding general population rates. Women and men reported equivalent total mean exposure to different trauma...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2nc8f30f</guid>
      <pubDate>Sat, 31 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Subica, Andrew M</name>
        <uri>https://orcid.org/0000-0001-6424-7668</uri>
      </author>
      <author>
        <name>Soakai, Lolofi</name>
      </author>
      <author>
        <name>Tukumoeatu, Amen</name>
      </author>
      <author>
        <name>Johnson, Taffy</name>
      </author>
      <author>
        <name>Aitaoto, Nia</name>
      </author>
    </item>
    <item>
      <title>Venous Thromboembolism in Metastatic Uterine Leiomyosarcoma: A Case Report and Review of the Literature</title>
      <link>https://escholarship.org/uc/item/2k71f8qd</link>
      <description>We report an unusual case of extensive deep vein thrombosis (DVT) and pulmonary embolism (PE) in the setting of metastatic uterine leiomyosarcoma. Recognition of the associated sequelae of this condition may improve short- and long-term outcomes. A 56-year-old black female with a history of uterine leiomyosarcoma diagnosed incidentally after total abdominal hysterectomy for fibroid uterus without initiation of chemoradiation treatment presented to the emergency department complaining of generalized weakness and progressively worsening stridor for 2 weeks. The patient was experiencing shortness of breath, dysphagia, and hoarseness. Physical exam was remarkable for rhonchi but was otherwise normal. Diagnostic imaging via CT of the abdomen, pelvis, and chest revealed DVTs of the left common and external iliac veins, the superior mesenteric artery, multiple pulmonary emboli of the right pulmonary artery, several nodular lesions within the lungs, and scattered peritoneal necrotic lesions,...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2k71f8qd</guid>
      <pubDate>Mon, 19 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Swisher, Austin R</name>
      </author>
      <author>
        <name>Ornelas, Denise</name>
      </author>
      <author>
        <name>Ornelas, Diana</name>
      </author>
      <author>
        <name>Namazi, Golnaz</name>
        <uri>https://orcid.org/0000-0002-5157-7243</uri>
      </author>
      <author>
        <name>Theodory, Bassam</name>
      </author>
      <author>
        <name>Chitkara, Akshit</name>
      </author>
      <author>
        <name>Desai, Aditya</name>
      </author>
      <author>
        <name>Sethi, Prabhdeep</name>
      </author>
    </item>
    <item>
      <title>Study protocol for a hybrid 1 effectiveness-implementation trial of Brief Skills Training in Affective and Interpersonal Regulation (Brief STAIR) and web-administered STAIR (webSTAIR) for posttraumatic stress disorder in integrated primary care</title>
      <link>https://escholarship.org/uc/item/35d2t0tn</link>
      <description>BACKGROUND: Posttraumatic stress disorder (PTSD) disproportionally affects low-income, racial and ethnic minoritized communities, where prevalence is high, yet access to evidence-based treatments (EBTs) is low. As such, there is a need to identify effective, feasible, and scalable interventions for PTSD. Stepped care approaches that include brief, low-intensity treatments are one approach to improving access yet have not been developed for adults with PTSD. Our study aims to test the effectiveness of a step one PTSD treatment in primary care while gathering information on implementation to maximize sustainability in the setting.
METHODS: This study will be conducted in integrated primary care in the largest safety net hospital in New England using a hybrid type 1 effectiveness-implementation design. Eligible trial participants are adult primary care patients who meet full or subthreshold criteria for PTSD. Interventions include Brief clinician-administered Skills Training in Affective...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/35d2t0tn</guid>
      <pubDate>Tue, 13 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Godfrey, Laura B</name>
      </author>
      <author>
        <name>Cloitre, Marylène</name>
      </author>
      <author>
        <name>Elwy, A Rani</name>
      </author>
      <author>
        <name>Fortuna, Lisa R</name>
        <uri>https://orcid.org/0000-0002-5336-4970</uri>
      </author>
      <author>
        <name>Fuchs, Cara</name>
      </author>
      <author>
        <name>Valentine, Sarah E</name>
      </author>
    </item>
    <item>
      <title>Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts.</title>
      <link>https://escholarship.org/uc/item/8dd1c02p</link>
      <description>&lt;b&gt;Rationale:&lt;/b&gt; Chronic obstructive pulmonary disease (COPD) is a complex disease characterized by airway obstruction and accelerated lung function decline. Our understanding of systemic protein biomarkers associated with COPD remains incomplete. &lt;b&gt;Objectives:&lt;/b&gt; To determine what proteins and pathways are associated with impaired pulmonary function in a diverse population. &lt;b&gt;Methods:&lt;/b&gt; We studied 6,722 participants across six cohort studies with both aptamer-based proteomic and spirometry data (4,566 predominantly White participants in a discovery analysis and 2,156 African American cohort participants in a validation). In linear regression models, we examined protein associations with baseline forced expiratory volume in 1 second (FEV&lt;sub&gt;1&lt;/sub&gt;) and FEV&lt;sub&gt;1&lt;/sub&gt;/forced vital capacity (FVC). In linear mixed effects models, we investigated the associations of baseline protein levels with rate of FEV&lt;sub&gt;1&lt;/sub&gt; decline (ml/yr) in 2,777 participants with up to 7 years...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8dd1c02p</guid>
      <pubDate>Thu, 8 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ngo, Debby</name>
      </author>
      <author>
        <name>Pratte, Katherine A</name>
      </author>
      <author>
        <name>Flexeder, Claudia</name>
      </author>
      <author>
        <name>Petersen, Hans</name>
      </author>
      <author>
        <name>Dang, Hong</name>
      </author>
      <author>
        <name>Ma, Yanlin</name>
      </author>
      <author>
        <name>Keyes, Michelle J</name>
      </author>
      <author>
        <name>Gao, Yan</name>
      </author>
      <author>
        <name>Deng, Shuliang</name>
      </author>
      <author>
        <name>Peterson, Bennet D</name>
      </author>
      <author>
        <name>Farrell, Laurie A</name>
      </author>
      <author>
        <name>Bhambhani, Victoria M</name>
      </author>
      <author>
        <name>Palacios, Cesar</name>
      </author>
      <author>
        <name>Quadir, Juweria</name>
      </author>
      <author>
        <name>Gillenwater, Lucas</name>
      </author>
      <author>
        <name>Xu, Hanfei</name>
      </author>
      <author>
        <name>Emson, Claire</name>
      </author>
      <author>
        <name>Gieger, Christian</name>
      </author>
      <author>
        <name>Suhre, Karsten</name>
      </author>
      <author>
        <name>Graumann, Johannes</name>
      </author>
      <author>
        <name>Jain, Deepti</name>
      </author>
      <author>
        <name>Conomos, Matthew P</name>
      </author>
      <author>
        <name>Tracy, Russell P</name>
      </author>
      <author>
        <name>Guo, Xiuqing</name>
      </author>
      <author>
        <name>Liu, Yongmei</name>
      </author>
      <author>
        <name>Johnson, W Craig</name>
      </author>
      <author>
        <name>Cornell, Elaine</name>
      </author>
      <author>
        <name>Durda, Peter</name>
      </author>
      <author>
        <name>Taylor, Kent D</name>
      </author>
      <author>
        <name>Papanicolaou, George J</name>
      </author>
      <author>
        <name>Rich, Stephen S</name>
      </author>
      <author>
        <name>Rotter, Jerome I</name>
        <uri>https://orcid.org/0000-0001-7191-1723</uri>
      </author>
      <author>
        <name>Rennard, Steven I</name>
      </author>
      <author>
        <name>Curtis, Jeffrey L</name>
      </author>
      <author>
        <name>Woodruff, Prescott G</name>
      </author>
      <author>
        <name>Comellas, Alejandro P</name>
      </author>
      <author>
        <name>Silverman, Edwin K</name>
      </author>
      <author>
        <name>Crapo, James D</name>
      </author>
      <author>
        <name>Larson, Martin G</name>
      </author>
      <author>
        <name>Vasan, Ramachandran S</name>
      </author>
      <author>
        <name>Wang, Thomas J</name>
      </author>
      <author>
        <name>Correa, Adolfo</name>
      </author>
      <author>
        <name>Sims, Mario</name>
      </author>
      <author>
        <name>Wilson, James G</name>
      </author>
      <author>
        <name>Gerszten, Robert E</name>
      </author>
      <author>
        <name>O'Connor, George T</name>
      </author>
      <author>
        <name>Barr, R Graham</name>
      </author>
      <author>
        <name>Couper, David</name>
      </author>
      <author>
        <name>Dupuis, Josée</name>
      </author>
      <author>
        <name>Manichaikul, Ani</name>
      </author>
      <author>
        <name>O'Neal, Wanda K</name>
      </author>
      <author>
        <name>Tesfaigzi, Yohannes</name>
      </author>
      <author>
        <name>Schulz, Holger</name>
      </author>
      <author>
        <name>Bowler, Russell P</name>
      </author>
    </item>
    <item>
      <title>Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among Medicare Beneficiaries</title>
      <link>https://escholarship.org/uc/item/49f79911</link>
      <description>BACKGROUND: The association of historical redlining policies, a marker of structural racism, with contemporary heart failure (HF) risk among White and Black individuals is not well established.
METHODS: We aimed to evaluate the association of redlining with the risk of HF among White and Black Medicare beneficiaries. Zip code-level redlining was determined by the proportion of historically redlined areas using the Mapping Inequality Project within each zip code. The association between higher zip code redlining proportion (quartile 4 versus quartiles 1-3) and HF risk were assessed separately among White and Black Medicare beneficiaries using generalized linear mixed models adjusted for potential confounders, including measures of the zip code-level Social Deprivation Index.
RESULTS: A total of 2 388 955 Medicare beneficiaries (Black n=801 452; White n=1 587 503; mean age, 71 years; men, 44.6%) were included. Among Black beneficiaries, living in zip codes with higher redlining...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/49f79911</guid>
      <pubDate>Thu, 1 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Mentias, Amgad</name>
      </author>
      <author>
        <name>Mujahid, Mahasin S</name>
        <uri>https://orcid.org/0000-0001-9795-9338</uri>
      </author>
      <author>
        <name>Sumarsono, Andrew</name>
      </author>
      <author>
        <name>Nelson, Robert K</name>
      </author>
      <author>
        <name>Madron, Justin M</name>
      </author>
      <author>
        <name>Powell-Wiley, Tiffany M</name>
      </author>
      <author>
        <name>Essien, Utibe R</name>
        <uri>https://orcid.org/0000-0002-4494-5028</uri>
      </author>
      <author>
        <name>Keshvani, Neil</name>
      </author>
      <author>
        <name>Girotra, Saket</name>
      </author>
      <author>
        <name>Morris, Alanna A</name>
      </author>
      <author>
        <name>Sims, Mario</name>
      </author>
      <author>
        <name>Capers, Quinn</name>
      </author>
      <author>
        <name>Yancy, Clyde</name>
      </author>
      <author>
        <name>Desai, Milind Y</name>
      </author>
      <author>
        <name>Menon, Venu</name>
      </author>
      <author>
        <name>Rao, Shreya</name>
      </author>
      <author>
        <name>Pandey, Ambarish</name>
      </author>
    </item>
    <item>
      <title>Transhiatal Herniation as the Cause of Acute Pancreatitis After Toupet Fundoplication</title>
      <link>https://escholarship.org/uc/item/2ks5g6db</link>
      <description>Hiatal translocation of the pancreas is rare because of its retroperitoneal location. Acute pancreatitis as a complication of hiatal hernia is uncommon. A 33-year-old man presented for 2 days of worsening epigastric abdominal pain and substernal chest pain. Laboratory studies were essentially unremarkable; however, computed tomography demonstrated a large right-sided hiatal hernia containing the entire stomach and the body of the pancreas, with peripancreatic edema consistent with pancreatitis. Most cases can be managed conservatively; however, elective surgical repair is suggested in severe cases or patients with low surgical risk.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2ks5g6db</guid>
      <pubDate>Thu, 1 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Zackria, Rasiq</name>
      </author>
      <author>
        <name>Popa, Alina</name>
      </author>
    </item>
    <item>
      <title>Use of an Opt-Out vs Opt-In Strategy Increases Use of Residency Mental Health Services.</title>
      <link>https://escholarship.org/uc/item/1m35g0sh</link>
      <description>&lt;b&gt;Background&lt;/b&gt; Residents report high levels of distress but low utilization of mental health services. Prior research has shown several barriers that prevent residents from opting into available mental health services. &lt;b&gt;Objective&lt;/b&gt; To determine the impact of a mental health initiative centered around an opt-out versus an opt-in approach to help-seeking, on the use of psychotherapy. &lt;b&gt;Methods&lt;/b&gt; Resident use of psychotherapy was compared between 2 time frames. During the first time frame (July 1, 2020 to January 31, 2021), residents were offered access to therapy that they could self-initiate by calling to schedule an appointment (opt-in). The second time frame (February 1, 2021 to April 30, 2021) involved the switch to an opt-out structure, during which the same residents were scheduled for a session but could choose to cancel. Additional changes were implemented to reduce stigma and minimize barriers. The outcome was psychotherapy use by residents. &lt;b&gt;Results&lt;/b&gt; Of...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1m35g0sh</guid>
      <pubDate>Thu, 1 Aug 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Guldner, Gregory</name>
      </author>
      <author>
        <name>Siegel, Jason T</name>
      </author>
      <author>
        <name>Broadbent, Chandler</name>
      </author>
      <author>
        <name>Ayutyanont, Napatkamon</name>
      </author>
      <author>
        <name>Streletz, Deborah</name>
      </author>
      <author>
        <name>Popa, Alina</name>
      </author>
      <author>
        <name>Fuller, Joshua</name>
      </author>
      <author>
        <name>Sisemore, Timothy</name>
      </author>
    </item>
    <item>
      <title>Treatment Referrals Post-prohibition of Alcohol Exclusion Laws: Evidence from Colorado and Illinois</title>
      <link>https://escholarship.org/uc/item/4rx5k0c3</link>
      <description>BackgroundIndividuals with alcohol-related disorders often encounter barriers to accessing treatment. One potential barrier is the state alcohol exclusion laws (AELs) that allow insurers to deny coverage for injuries or illnesses caused by alcohol intoxication. Several states have repealed AELs by prohibiting them completely, including banning exclusions in health and accident insurance policies, limiting their scope, or creating exemptions.ObjectivesTo examine whether prohibiting alcohol exclusions in health and accident insurance policies is associated with alcohol-related treatment admissions.DesignWe used the 2002 to 2017 Treatment Episode Data Set and obtained data from several sources to control for state-level factors. We employed a heterogeneous difference-in-differences method and an event study to compare the treatment admissions in Colorado and Illinois, two states that uniquely repealed AELs, with control states that allowed or had no AELs.Main MeasuresWe used aggregated...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4rx5k0c3</guid>
      <pubDate>Wed, 24 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Azagba, Sunday</name>
      </author>
      <author>
        <name>Ebling, Todd</name>
      </author>
      <author>
        <name>Shan, Lingping</name>
      </author>
      <author>
        <name>Hall, Mark</name>
      </author>
      <author>
        <name>Wolfson, Mark</name>
      </author>
    </item>
    <item>
      <title>Trends in presumed drug overdose out-of-hospital cardiac arrests in San Francisco, 2015–2023</title>
      <link>https://escholarship.org/uc/item/6nz9g0m3</link>
      <description>INTRODUCTION: Estimates of the prevalence of drug-related out of hospital cardiac arrest (OHCA) vary, ranging from 1.8% to 10.0% of medical OHCA. However, studies conducted prior to the recent wave of fentanyl deaths likely underestimate the current prevalence of drug-related OHCA. We evaluated recent trends in drug-related OHCA, hypothesizing that the proportion of presumed drug-related OHCA treated by emergency medical services (EMS) has increased since 2015.
METHODS: We conducted a retrospective analysis of OHCA patients treated by EMS providers in San Francisco, California between 2015 and 2023. Participants included OHCA cases in which resuscitation was attempted by EMS. The study exposure was the year of arrest. Our primary outcome was the occurrence of drug-related OHCA, defined as the EMS impression of OHCA caused by a presumed or known overdose of medication(s) or drug(s).
RESULTS: From 2015 to 2023, 5044 OHCA resuscitations attended by EMS (average 561 per year) met...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6nz9g0m3</guid>
      <pubDate>Mon, 8 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Wang, Ralph C</name>
        <uri>https://orcid.org/0000-0001-5382-9486</uri>
      </author>
      <author>
        <name>Montoy, Juan Carlos C</name>
        <uri>https://orcid.org/0000-0001-7438-0243</uri>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Menegazzi, James J</name>
      </author>
      <author>
        <name>Lacocque, Jeremy</name>
        <uri>https://orcid.org/0000-0003-2221-7705</uri>
      </author>
      <author>
        <name>Dillon, David G</name>
        <uri>https://orcid.org/0000-0003-0729-0162</uri>
      </author>
    </item>
    <item>
      <title>Screening performance of the chest X-ray in adult blunt trauma evaluation: Is it effective and what does it miss?</title>
      <link>https://escholarship.org/uc/item/6cn2r0r1</link>
      <description>BACKGROUND: Although chest x-ray (CXR) is often used as a screening tool for thoracic injury in adult blunt trauma assessment, its screening performance is unclear. Using chest CT as the referent standard, we sought to determine the screening performance of CXR for injury.
METHODS: We analyzed data from the NEXUS Chest CT study, in which we prospectively enrolled blunt trauma patients older than 14 years who received chest imaging as part of their evaluation at nine level I trauma centers. For this analysis, we included patients who had both CXR and chest CT. We used CT as the referent standard and categorized injuries as clinically major or minor according to an a priori expert panel classification.
RESULTS: Of 11,477 patients enrolled, 4501 had both CXR and chest CT; 1496 (33.2%) were found to have injury, of which 256 (17%) were classified as major injury. CXR missed injuries in 818 patients (54.7%), of which 63 (7.7%) were classified as major injuries. For injuries of major...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6cn2r0r1</guid>
      <pubDate>Tue, 2 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Dillon, David G</name>
        <uri>https://orcid.org/0000-0003-0729-0162</uri>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
    </item>
    <item>
      <title>“If he doesn’t buy in, it’s a waste of time”: Perspectives from diverse parents and adolescents on engaging children in ADHD treatment</title>
      <link>https://escholarship.org/uc/item/3bp7s7s2</link>
      <description>Engaging children and adolescents in ADHD care is critical for future independent disease management. However, there is a lack of evidence guiding health professionals and parents on how best to engage their children and adolescents in ADHD care. We recruited 41 diverse parents of children and adolescents with ADHD and 11 adolescents with ADHD from an urban, safety-net hospital to participate in in-depth,&amp;nbsp;semi-structured qualitative interviews and then analyzed this data using thematic analysis. Children’s level of illness insight about ADHD and self-esteem emerged as two major contributors to engagement of children and adolescents in ADHD care, and their intersection created four styles of engagement: proactive (high insight, high self-esteem), anxious (high insight, low self-esteem), apathetic (low insight, high self-esteem), and resistant (low insight, low self-esteem). This framework can help health professionals engage children and adolescents in care for ADHD and guide...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3bp7s7s2</guid>
      <pubDate>Mon, 1 Jul 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Zolli, Nicole</name>
      </author>
      <author>
        <name>Loubeau, J Krystel</name>
      </author>
      <author>
        <name>Sikov, Jennifer</name>
      </author>
      <author>
        <name>Baul, Tithi D</name>
      </author>
      <author>
        <name>Hasan, Syeda</name>
      </author>
      <author>
        <name>Rosen, Katherine</name>
      </author>
      <author>
        <name>Buonocore, Olivia</name>
      </author>
      <author>
        <name>Rabin, Megan</name>
      </author>
      <author>
        <name>Duncan, Alison</name>
      </author>
      <author>
        <name>Fortuna, Lisa</name>
        <uri>https://orcid.org/0000-0002-5336-4970</uri>
      </author>
      <author>
        <name>Borba, Christina PC</name>
      </author>
      <author>
        <name>Silverstein, Michael</name>
      </author>
      <author>
        <name>Spencer, Andrea E</name>
      </author>
    </item>
    <item>
      <title>“Ancestral recipes”: a mixed-methods analysis of MyPlate-based recipe dissemination for Latinos in rural communities</title>
      <link>https://escholarship.org/uc/item/2q1830wj</link>
      <description>BackgroundThe Latinx population experiences some of the highest rates of chronic disease, including obesity and type II diabetes. Such conditions may be especially burdensome in rural Latinx communities that often face barriers to accessing disease prevention resources and public health programs.MethodsDiverse stakeholders (i.e., patients, community members, system of healthcare clinics, community food bank) tailored an existing cookbook, based on the U.S. Department of Agriculture MyPlate healthy eating and dietary guidelines, for local ingredients, health literacy, and language for rural Latinx&amp;nbsp;and&amp;nbsp;Indigenous Latin Americans. The cookbook recipes were disseminated widely via virtual cooking demonstrations, food distribution events, and social media. Pre- and posttest surveys were used to assess changes in diabetes knowledge measured by the 24-item American Diabetes Association Diabetic Knowledge Questionnaire and confidence in dietary behavior change over time measured...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2q1830wj</guid>
      <pubDate>Mon, 24 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Cheney, Ann Marie</name>
        <uri>https://orcid.org/0000-0002-4032-6692</uri>
      </author>
      <author>
        <name>McCarthy, William J</name>
      </author>
      <author>
        <name>Pozar, María</name>
      </author>
      <author>
        <name>Reaves, Christina</name>
      </author>
      <author>
        <name>Ortiz, Gabriela</name>
      </author>
      <author>
        <name>Lopez, Diana</name>
      </author>
      <author>
        <name>Saldivar, Perla A</name>
      </author>
      <author>
        <name>Gelberg, Lillian</name>
        <uri>https://orcid.org/0000-0001-9772-0116</uri>
      </author>
    </item>
    <item>
      <title>Recovery From Mobility Limitation in Middle-Aged African Americans: The Jackson Heart Study</title>
      <link>https://escholarship.org/uc/item/1007w246</link>
      <description>BACKGROUND: Despite evidence that African Americans shoulder a high burden of mobility limitation, little is known about factors associated with recovery.
METHOD: Participants from the Jackson Heart Study underwent 3 in-person exams from 2000 to 2013. Mobility limitations were assessed over this period by self-reported limitations in walking half a mile or climbing stairs during annual phone calls. The outcome of interest, recovery from mobility limitation, was defined as no mobility limitation the year following an incident event. Candidate predictor variables were assessed in logistic regression models, including sociodemographic, psychosocial, and health measures. Inverse probability weights were used to address missing data in the outcome.
RESULTS: Among 4526 participants (mean [SD] age = 54.5 (12.8) years) without a mobility limitation at baseline, 1445 (32%) had an incident mobility limitation over 12 years of follow-up, and 709 (49%) reported recovery from mobility limitation...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1007w246</guid>
      <pubDate>Mon, 24 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Odden, Michelle C</name>
      </author>
      <author>
        <name>Sims, Kendra D</name>
        <uri>https://orcid.org/0000-0002-6740-3002</uri>
      </author>
      <author>
        <name>Thorpe, Roland J</name>
      </author>
      <author>
        <name>Sims, Mario</name>
      </author>
      <author>
        <name>Dhamoon, Mandip</name>
      </author>
      <author>
        <name>Min, Yuan-I</name>
      </author>
      <author>
        <name>Correa, Adolfo</name>
      </author>
    </item>
    <item>
      <title>English-based Pediatric Emergency Medicine Software Improves Physician Test Performance on Common Pediatric Emergencies: A Multicenter Study in Vietnam</title>
      <link>https://escholarship.org/uc/item/28c2r58k</link>
      <description>INTRODUCTION: Global health agencies and the Vietnam Ministry of Health have identified pediatric emergency care and health information technology as high priority goals. Clinical decision support (CDS) software provides physicians with access to current literature to answer clinical queries, but there is limited impact data in developing countries. We hypothesized that Vietnamese physicians will demonstrate improved test performance on common pediatric emergencies using CDS technologies despite being in English.
METHODS: This multicenter, prospective, pretest-posttest study was conducted in 11 Vietnamese hospitals enrolled a convenience sample of physicians who attended an 80-minute software training on a pediatric CDS software (PEMSoft). Two multiple-choice exams (A, B) were administered before and after the session. Participants, who received Test A as a pretest, received Test B as a posttest, and vice versa. Participants used the CDS software for the posttest. The primary...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/28c2r58k</guid>
      <pubDate>Mon, 17 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lin, Michelle</name>
      </author>
      <author>
        <name>Brooks, Trevor N</name>
      </author>
      <author>
        <name>Miller, Alex C</name>
      </author>
      <author>
        <name>Sharp, Jamie L</name>
      </author>
      <author>
        <name>Hai, Le Thanh</name>
      </author>
      <author>
        <name>Nguyen, Tu</name>
      </author>
      <author>
        <name>Kievlan, Daniel R</name>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Dieckmann, Ronald A</name>
      </author>
    </item>
    <item>
      <title>Depression, Suicidal Ideation, and Suicidal Attempt Presenting to the Emergency Department: Differences Between These Cohorts</title>
      <link>https://escholarship.org/uc/item/8pm255zt</link>
      <description>INTRODUCTION: The World Health Organization estimates that one million people die by suicide every year. Few studies have looked at factors associated with disposition in patients with chief complaints of depression, suicidal ideation (SI) and suicidal attempts (SA) who present to the emergency department (ED). Our objective was to assess individual determinants associated with ED disposition of patients in depressed patients presenting to the ED.
METHODS: We conducted a retrospective study using the National Hospital Ambulatory Medical Care Survey from 2006 to 2008. We used logistic regression to identify factors associated with discharge, in SI, SA and depression patients. Independent variables included socio-demographic information, vital signs, mode of arrival, insurance status, place of residence and concomitant psychiatric diagnosis.
RESULTS: Of the 93,030 subjects, 2,314 met the inclusion criteria (1,362 depression, 353 SI and 599 SA). Patients who arrived by ambulance...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/8pm255zt</guid>
      <pubDate>Sun, 16 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Chakravarthy, Bharath</name>
        <uri>https://orcid.org/0000-0002-8568-4709</uri>
      </author>
      <author>
        <name>Hoonpongsimanont, Wirachin</name>
        <uri>https://orcid.org/0000-0003-0507-7149</uri>
      </author>
      <author>
        <name>Anderson, Craig L</name>
      </author>
      <author>
        <name>Habicht, Michael</name>
      </author>
      <author>
        <name>Bruckner, Tim</name>
      </author>
      <author>
        <name>Lotfipour, Shahram</name>
        <uri>https://orcid.org/0000-0003-3437-9410</uri>
      </author>
    </item>
    <item>
      <title>Post-Visit Patient Understanding About Newly Prescribed Medications</title>
      <link>https://escholarship.org/uc/item/9jr238v4</link>
      <description>BackgroundGood patient understanding of basic medication-related information such as directions for use and side effects promotes medication adherence, but information is lacking about how well patients understand basic medication-related information after their office visits.ObjectiveThe purpose of this study is to investigate post-visit patient understanding about newly prescribed medications.DesignSecondary mixed methods analysis comparing patient survey responses about newly prescribed medications to information conveyed by physicians during office visits (from audio recordings of office visits).ParticipantsEighty-one patients aged 50 and older who discussed newly prescribed medications during an outpatient office visit.Main MeasuresAccurate patient identification of medication dose, number of pills, frequency of use, duration of use, and potential side effects.Key ResultsThe 81 patients in this study received 111 newly prescribed medications. For over 70% of all newly prescribed...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9jr238v4</guid>
      <pubDate>Tue, 11 Jun 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ho, Timothy</name>
      </author>
      <author>
        <name>Campos, Blanca S</name>
      </author>
      <author>
        <name>Tarn, Derjung M</name>
        <uri>https://orcid.org/0000-0001-7426-6387</uri>
      </author>
    </item>
    <item>
      <title>Traumatic injury to the posterior fossa: a secondary analysis and description of case series from the NEXUS head injury dataset</title>
      <link>https://escholarship.org/uc/item/59v4m78n</link>
      <description>Background: Traumatic brain injuries involving the posterior fossa are rare and case reports indicate they often result in severe outcomes. We seek to describe characteristics and outcomes of traumatic posterior fossa injuries.
Methods: We performed a planned secondary analysis of all patients with posterior fossa injuries enrolled in the NEXUS head computed tomography (CT) validation study dataset. The dataset includes prospectively collected data on all patients undergoing non-contrast cranial CT following blunt traumatic head injury from April 2006 to December 2015, at four emergency departments comprising community and university sites, as well as urban, suburban and rural settings in California (Antelope Valley Hospital, San Francisco General Hospital, UCLA Ronald Reagan Medical Center, UCSF Fresno Community Regional Medical Center). We classified each patient into one of three injury patterns: Type I-notable traumatic injuries primarily above the tentorium, with minimal...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/59v4m78n</guid>
      <pubDate>Wed, 29 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Cooper, Richelle J</name>
      </author>
      <author>
        <name>Akie, Thomas E</name>
      </author>
      <author>
        <name>Gujral, Tarika</name>
      </author>
      <author>
        <name>Rana, Shivam</name>
      </author>
      <author>
        <name>Bui, Kyle</name>
      </author>
      <author>
        <name>Factora, Ryan</name>
      </author>
      <author>
        <name>Quinones, Alexandra</name>
      </author>
      <author>
        <name>Gupta, Malkeet</name>
      </author>
      <author>
        <name>Hendey, Gregory W</name>
        <uri>https://orcid.org/0000-0002-0170-8743</uri>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Mower, William R</name>
      </author>
    </item>
    <item>
      <title>Point-of-Sale Health Communication Campaigns for Cigarillos and Waterpipe Tobacco: Effects and Lessons Learned from Two Cluster Randomized Trials</title>
      <link>https://escholarship.org/uc/item/3h4352bt</link>
      <description>Many adolescents and young adults hold erroneous beliefs that cigarillos and waterpipe tobacco (WT) are safer than cigarettes, contributing to use. Communication campaigns can correct misperceptions and increase risk beliefs. We tested point-of-sale (POS) communication campaigns focused on chemical exposure for cigarillos and WT. We conducted two cluster randomized trials at 20 gas stations with convenience stores (10 stores for cigarillos, 10 for WT) in North Carolina between June and November 2017. Within each trial, stores were randomly assigned to either the intervention (campaign messages displayed) or a no message control condition. We conducted intercept surveys with repeated cross-sectional samples of 50 adolescents and young adults (ages 16-25) per store, at baseline and follow-up. There were 978 participants (mean age&amp;nbsp;=&amp;nbsp;20.9&amp;nbsp;years) in the cigarillo trial, and 998 participants (mean age&amp;nbsp;=&amp;nbsp;21.0&amp;nbsp;years) in the WT trial. Rates of campaign exposure...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3h4352bt</guid>
      <pubDate>Wed, 15 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Sutfin, Erin L</name>
      </author>
      <author>
        <name>Lazard, Allison J</name>
      </author>
      <author>
        <name>Wagoner, Kimberly G</name>
      </author>
      <author>
        <name>King, Jessica L</name>
      </author>
      <author>
        <name>Ross, Jennifer Cornacchione</name>
      </author>
      <author>
        <name>Wiseman, Kimberly D</name>
      </author>
      <author>
        <name>Orlan, Elizabeth N</name>
      </author>
      <author>
        <name>Suerken, Cynthia K</name>
      </author>
      <author>
        <name>Reboussin, David M</name>
      </author>
      <author>
        <name>Wolfson, Mark</name>
      </author>
      <author>
        <name>Noar, Seth M</name>
      </author>
      <author>
        <name>Reboussin, Beth A</name>
      </author>
    </item>
    <item>
      <title>Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids</title>
      <link>https://escholarship.org/uc/item/9908p5jw</link>
      <description>BACKGROUND: In the US, over 200 lives are lost from opioid overdoses each day. Accurate and prompt diagnosis of opioid use disorders (OUD) may help prevent overdose deaths. However, international classification of disease (ICD) codes for OUD are known to underestimate prevalence, and their specificity and sensitivity are unknown. We developed and validated algorithms to identify OUD in electronic health records (EHR) and examined the validity of OUD ICD codes.
METHODS: Through four iterations, we developed EHR-based OUD identification algorithms among patients who were prescribed opioids from 2014 to 2017. The algorithms and OUD ICD codes were validated against 169 independent "gold standard" EHR chart reviews conducted by an expert adjudication panel across four healthcare systems. After using 2014-2020 EHR for validating iteration 1, the experts were advised to use 2014-2017 EHR thereafter.
RESULTS: Of the 169 EHR charts, 81 (48%) were reviewed by more than one expert and exhibited...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/9908p5jw</guid>
      <pubDate>Mon, 6 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Ranapurwala, Shabbar I</name>
      </author>
      <author>
        <name>Alam, Ishrat Z</name>
      </author>
      <author>
        <name>Pence, Brian W</name>
      </author>
      <author>
        <name>Carey, Timothy S</name>
      </author>
      <author>
        <name>Christensen, Sean</name>
      </author>
      <author>
        <name>Clark, Marshall</name>
      </author>
      <author>
        <name>Chelminski, Paul R</name>
      </author>
      <author>
        <name>Wu, Li‐Tzy</name>
      </author>
      <author>
        <name>Greenblatt, Lawrence H</name>
      </author>
      <author>
        <name>Korte, Jeffrey E</name>
      </author>
      <author>
        <name>Wolfson, Mark</name>
      </author>
      <author>
        <name>Douglas, Heather E</name>
      </author>
      <author>
        <name>Bowlby, Lynn A</name>
      </author>
      <author>
        <name>Capata, Michael</name>
      </author>
      <author>
        <name>Marshall, Stephen W</name>
      </author>
    </item>
    <item>
      <title>Availability and use of institutional support programs for emergency department healthcare personnel during the COVID-19 pandemic</title>
      <link>https://escholarship.org/uc/item/2128n26x</link>
      <description>OBJECTIVES: The COVID-19 pandemic placed health care personnel (HCP) at risk for stress, anxiety, burnout, and post-traumatic stress disorder (PTSD). To address this, hospitals developed programs to mitigate risk. The objectives of the current study were to measure the availability and use of these programs in a cohort of academic emergency departments (EDs) in the United States early in the pandemic and identify factors associated with program use.
METHODS: Cross-sectional survey of ED HCP in 21 academic EDs in 15 states between June and September 2020. Site investigators provided data on the availability of 28 programs grouped into 9 categories. Individual support programs included: financial, workload mitigation, individual COVID-19 testing, emotional (e.g., mental health hotline), and instrumental (e.g., childcare) Clinical work support programs included: COVID-19 team communication (e.g., debriefing critical incident), patient-family communication facilitation, patient services...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2128n26x</guid>
      <pubDate>Mon, 6 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hoth, Karin F</name>
      </author>
      <author>
        <name>Eyck, Patrick Ten</name>
      </author>
      <author>
        <name>Harland, Karisa K</name>
      </author>
      <author>
        <name>Krishnadasan, Anusha</name>
      </author>
      <author>
        <name>Rodriguez, Robert M</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Montoy, Juan Carlos C</name>
        <uri>https://orcid.org/0000-0001-7438-0243</uri>
      </author>
      <author>
        <name>Wendt, Linder H</name>
      </author>
      <author>
        <name>Mower, William</name>
      </author>
      <author>
        <name>Wallace, Kelli</name>
      </author>
      <author>
        <name>Santibañez, Scott</name>
      </author>
      <author>
        <name>Talan, David A</name>
      </author>
      <author>
        <name>Mohr, Nicholas M</name>
      </author>
      <author>
        <name>Network, for the Project COVERED Emergency Department</name>
      </author>
    </item>
    <item>
      <title>Outcomes after cardiac arrest in Medical Intensive Care Unit: A propensity score matching analysis of COVID-19 MICU vs non COVID-19 MICU cardiac arrest.</title>
      <link>https://escholarship.org/uc/item/6z02m8md</link>
      <description>AIM: To assess whether there were differences in resuscitation efforts and outcomes for medical intensive care unit (MICU) in-hospital cardiac arrest (IHCA) during the COVID-19 pandemic when compared to pre-pandemic. METHODS: Comparing COVID-19 MICU-IHCA patients (03/2020 to 10/2020) to non-COVID-19 MICU IHCA (01/2014 to 12/2018) at Clevleand Clinic Health System (CCHS) of NE Ohio. Propensity score matching analysis (PSMA) was used to create comparable groups. RESULTS: There were a total of 516 patients, 51 in COVID-19 MICU IHCA cohort and 465 in the non-COVID-19 MICU IHCA cohort. The mean (SD) age of the study population was 60.9 (16) years and 56% were males. In 92.1% (n&amp;nbsp;=&amp;nbsp;475) patients, initial arrest rhythm was non-shockable. At the time of ICU admission, compared to the non-COVID-19 MICU-IHCA cohort, the COVID-19 MICU IHCA cohort had a lower mean APACHE III score (70 [32.9] vs 101.3 [39.6], P&amp;nbsp;=&amp;nbsp;&amp;lt;0.01). The COVID-19 cohort had a higher rate of survival...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/6z02m8md</guid>
      <pubDate>Sat, 4 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Bhardwaj, Abhishek</name>
      </author>
      <author>
        <name>Alwakeel, Mahmoud</name>
      </author>
      <author>
        <name>Kirincich, Jason</name>
      </author>
      <author>
        <name>Shaheen, Hassan</name>
      </author>
      <author>
        <name>Gaieski, David</name>
      </author>
      <author>
        <name>Abella, Benjamin</name>
      </author>
      <author>
        <name>Wang, Xiaofeng</name>
      </author>
      <author>
        <name>Al-Jaghbeer, Mohammed</name>
      </author>
      <author>
        <name>Duggal, Abhijit</name>
      </author>
      <author>
        <name>Abi Fadel, Francois</name>
      </author>
      <author>
        <name>Krishnan, Sudhir</name>
      </author>
    </item>
    <item>
      <title>Machine learning model to predict evolution of pulseless electrical activity during in-hospital cardiac arrest</title>
      <link>https://escholarship.org/uc/item/0mt924m9</link>
      <description>Background: During pulseless electrical activity (PEA) the cardiac mechanical and electrical functions are dissociated, a phenomenon occurring in 25-42% of in-hospital cardiac arrest (IHCA) cases. Accurate evaluation of the likelihood of a PEA patient transitioning to return of spontaneous circulation (ROSC) may be vital for the successful resuscitation.
The aim: We sought to develop a model to automatically discriminate between PEA rhythms with favorable and unfavorable evolution to ROSC.
Methods: A dataset of 190 patients, 120 with ROSC, were acquired with defibrillators from different vendors in three hospitals. The ECG and the transthoracic impedance (TTI) signal were processed to compute 16 waveform features. Logistic regression models where designed integrating both automated features and characteristics annotated in the QRS to identify PEAs with better prognosis leading to ROSC. Cross validation techniques were applied, both patient-specific and stratified, to evaluate...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0mt924m9</guid>
      <pubDate>Sat, 4 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Urteaga, Jon</name>
      </author>
      <author>
        <name>Elola, Andoni</name>
      </author>
      <author>
        <name>Norvik, Anders</name>
      </author>
      <author>
        <name>Unneland, Eirik</name>
      </author>
      <author>
        <name>Eftestøl, Trygve C</name>
      </author>
      <author>
        <name>Bhardwaj, Abhishek</name>
      </author>
      <author>
        <name>Buckler, David</name>
      </author>
      <author>
        <name>Abella, Benjamin S</name>
      </author>
      <author>
        <name>Skogvoll, Eirik</name>
      </author>
      <author>
        <name>Aramendi, Elisabete</name>
      </author>
    </item>
    <item>
      <title>Examining the Relationship Between Multilevel Resilience Resources and Cardiovascular Disease Incidence, Overall and by Psychosocial Risks, Among Participants in the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study</title>
      <link>https://escholarship.org/uc/item/2c0715b3</link>
      <description>We examined relationships between resilience resources (optimism, social support, and neighborhood social cohesion) and cardiovascular disease (CVD) incidence and assessed potential effect-measure modification by psychosocial risk factors (e.g., stress, depression) among adults without CVD in 3 cohort studies (2000-2018): the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. We fitted adjusted Cox models accounting for within-neighborhood clustering while censoring at dropout or non-CVD death. We assessed for effect-measure modification by psychosocial risks. In secondary analyses, we estimated standardized risk ratios using inverse-probability-weighted Aalen-Johansen estimators to account for confounding, dropout, and competing risks (non-CVD deaths) and obtained 95% confidence intervals (CIs) using cluster bootstrapping. For high and medium (versus low) optimism (n&amp;nbsp;=&amp;nbsp;6,243),...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/2c0715b3</guid>
      <pubDate>Wed, 1 May 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Park, Jee Won</name>
      </author>
      <author>
        <name>Dulin, Akilah J</name>
      </author>
      <author>
        <name>Scarpaci, Matthew M</name>
      </author>
      <author>
        <name>Dionne, Laura A</name>
      </author>
      <author>
        <name>Needham, Belinda L</name>
      </author>
      <author>
        <name>Sims, Mario</name>
      </author>
      <author>
        <name>Kanaya, Alka M</name>
        <uri>https://orcid.org/0000-0002-8903-1457</uri>
      </author>
      <author>
        <name>Kandula, Namratha R</name>
      </author>
      <author>
        <name>Loucks, Eric B</name>
      </author>
      <author>
        <name>Fava, Joseph L</name>
      </author>
      <author>
        <name>Eaton, Charles B</name>
      </author>
      <author>
        <name>Howe, Chanelle J</name>
      </author>
    </item>
    <item>
      <title>Toward decolonized fiscal relationships between universities and community organizations: lessons learned from the California community engagement alliance against COVID-19</title>
      <link>https://escholarship.org/uc/item/0g5421g9</link>
      <description>In September 2020 the US National Institutes of Health (NIH) allocated $12 million to support engagement with historically marginalized communities hardest hit by COVID-19. The award was designed to mobilize community-engagement in pandemic response, and to support partnerships as part of the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities. All aspects of the award were fast-tracked and NIH utilized a 'more flexible' funding mechanism (OTA) to facilitate swift distribution of funds. In this paper, we draw upon an analysis of findings from a 2021 survey conducted with 11 California CEAL sites representing urban and rural settings, private and public universities, and established and new community partners and qualitative analysis of 2020-2022 site-wide meeting minutes. We describe challenges posed at the federal (e.g., NIH funding), university, and community-university partnership levels as well as opportunities and creative workarounds. Challenges include...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/0g5421g9</guid>
      <pubDate>Fri, 26 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Burke, Nancy J</name>
        <uri>https://orcid.org/0000-0002-2269-3341</uri>
      </author>
      <author>
        <name>Espinosa, Patricia Rodriguez</name>
      </author>
      <author>
        <name>Corchado, Claudia C</name>
      </author>
      <author>
        <name>Vázquez, Evelyn</name>
      </author>
      <author>
        <name>Rosas, Lisa G</name>
      </author>
      <author>
        <name>Wooe, Kent J</name>
      </author>
      <author>
        <name>LeSarre, Monique</name>
      </author>
      <author>
        <name>Gallegos-Castillo, Angela</name>
      </author>
      <author>
        <name>Cheney, Ann</name>
        <uri>https://orcid.org/0000-0002-4032-6692</uri>
      </author>
      <author>
        <name>Lo, David D</name>
        <uri>https://orcid.org/0000-0002-5962-9458</uri>
      </author>
      <author>
        <name>Hintz, Rachel</name>
      </author>
      <author>
        <name>Vassar, Stefanie D</name>
      </author>
      <author>
        <name>Brown, Arleen F</name>
        <uri>https://orcid.org/0000-0001-9948-8955</uri>
      </author>
    </item>
    <item>
      <title>Cryoglobulinemia Leading to the Diagnosis of Low Grade Serous Ovarian Carcinoma</title>
      <link>https://escholarship.org/uc/item/4mk2b7t3</link>
      <description>We present the case of a 64-year-old female who was referred by her oncologist to benign hematology clinic for persistent asymptomatic cryoglobulinemia. Workup led to diagnosis of a rare low grade ovarian serous carcinoma. We briefly review the pathophysiology and clinical significance of cryoglobulinemia and the diagnosis and management of low grade serous ovarian carcinoma.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/4mk2b7t3</guid>
      <pubDate>Mon, 15 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Hagopian, Garo</name>
      </author>
      <author>
        <name>Grant, Christopher</name>
      </author>
      <author>
        <name>Lou, Jerry</name>
      </author>
      <author>
        <name>Johnson, Cary</name>
      </author>
      <author>
        <name>Pakbaz, Zahra</name>
      </author>
    </item>
    <item>
      <title>A Journey From Appendicitis to a Rare Appendiceal Mucinous Neoplasm</title>
      <link>https://escholarship.org/uc/item/1rf9j45p</link>
      <description>We present here a 66-year-old Caucasian male whose persistent abdominal pain thought to be due to appendicitis and associated acute splanchnic thrombosis. He was initially managed with antibiotics and anticoagulation. But further work up revealed a low-grade appendiceal mucinous neoplasm causing the splanchnic vein thrombosis. Additionally, diagnosis and management of this rare tumor and appropriate work up for splanchnic thrombosis will be briefly reviewed here.</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/1rf9j45p</guid>
      <pubDate>Mon, 15 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Grant, Christopher</name>
      </author>
      <author>
        <name>Hagopian, Garo</name>
      </author>
      <author>
        <name>Ponce-Zepeda, Joaquin</name>
      </author>
      <author>
        <name>Chandan, Vishal</name>
      </author>
      <author>
        <name>Pakbaz, Zahra</name>
      </author>
    </item>
    <item>
      <title>Implementation of the I‐PASS handoff program in diverse clinical environments: A multicenter prospective effectiveness implementation study</title>
      <link>https://escholarship.org/uc/item/00j3s863</link>
      <description>BACKGROUND: Handoff miscommunications are a leading source of medical errors. Harmful medical errors decreased in pediatric academic hospitals following implementation of the I-PASS handoff improvement program. However, implementation across specialties has not been assessed.
OBJECTIVE: To determine if I-PASS implementation across diverse settings would be associated with improvements in patient safety and communication.
DESIGN: Prospective Type 2 Hybrid effectiveness implementation study.
SETTINGS AND PARTICIPANTS: Residents from diverse specialties across 32 hospitals (12 community, 20 academic).
INTERVENTION: External teams provided longitudinal coaching over 18 months to facilitate implementation of an enhanced I-PASS program and monthly metric reviews.
MAIN OUTCOME AND MEASURES: Systematic surveillance surveys assessed rates of resident-reported adverse events. Validated direct observation tools measured verbal and written handoff quality.
RESULTS: 2735 resident physicians...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/00j3s863</guid>
      <pubDate>Wed, 3 Apr 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Starmer, Amy J</name>
      </author>
      <author>
        <name>Spector, Nancy D</name>
      </author>
      <author>
        <name>O'Toole, Jennifer K</name>
      </author>
      <author>
        <name>Bismilla, Zia</name>
      </author>
      <author>
        <name>Calaman, Sharon</name>
      </author>
      <author>
        <name>Campos, Maria‐Lucia</name>
      </author>
      <author>
        <name>Coffey, Maitreya</name>
      </author>
      <author>
        <name>Destino, Lauren A</name>
      </author>
      <author>
        <name>Everhart, Jennifer L</name>
      </author>
      <author>
        <name>Goldstein, Jenna</name>
      </author>
      <author>
        <name>Graham, Dionne A</name>
      </author>
      <author>
        <name>Hepps, Jennifer H</name>
      </author>
      <author>
        <name>Howell, Eric E</name>
      </author>
      <author>
        <name>Kuzma, Nicholas</name>
      </author>
      <author>
        <name>Maynard, Greg</name>
      </author>
      <author>
        <name>Melvin, Patrice</name>
      </author>
      <author>
        <name>Patel, Shilpa J</name>
      </author>
      <author>
        <name>Popa, Alina</name>
      </author>
      <author>
        <name>Rosenbluth, Glenn</name>
      </author>
      <author>
        <name>Schnipper, Jeffrey L</name>
      </author>
      <author>
        <name>Sectish, Theodore C</name>
      </author>
      <author>
        <name>Srivastava, Rajendu</name>
      </author>
      <author>
        <name>West, Daniel C</name>
      </author>
      <author>
        <name>Yu, Clifton E</name>
      </author>
      <author>
        <name>Landrigan, Christopher P</name>
      </author>
      <author>
        <name>Group, the I‐PASS SHM Mentored Implementation Study</name>
      </author>
    </item>
    <item>
      <title>A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies</title>
      <link>https://escholarship.org/uc/item/58q838sz</link>
      <description>PURPOSE: The lipoate derivative CPI-613 is a first-in-class agent that targets mitochondrial metabolism. This study determined the effects of CPI-613 on mitochondrial function and defined the MTD, pharmacokinetics, and safety in patients with relapsed or refractory hematologic malignancies.
EXPERIMENTAL DESIGN: Human leukemia cell lines were exposed to CPI-613 and mitochondrial function was assayed. A phase I trial was conducted in which CPI-613 was given as a 2-hour infusion on days 1 and 4 for 3 weeks every 28 days.
RESULTS: CPI-613 inhibited mitochondrial respiration of human leukemia cells consistent with the proposed mechanism of action. In the phase I trial, 26 patients were enrolled. CPI-613 was well tolerated with no marrow suppression observed. When the infusion time was shortened to 1 hour, renal failure occurred in 2 patients. At 3,780 mg/m(2), there were two dose-limiting toxicities (DLT). At a dose of 2,940 mg/m(2) over 2 hours, no DLTs were observed, establishing...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/58q838sz</guid>
      <pubDate>Fri, 29 Mar 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Pardee, Timothy S</name>
      </author>
      <author>
        <name>Lee, King</name>
      </author>
      <author>
        <name>Luddy, John</name>
      </author>
      <author>
        <name>Maturo, Claudia</name>
      </author>
      <author>
        <name>Rodriguez, Robert</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Isom, Scott</name>
      </author>
      <author>
        <name>Miller, Lance D</name>
      </author>
      <author>
        <name>Stadelman, Kristin M</name>
      </author>
      <author>
        <name>Levitan, Denise</name>
      </author>
      <author>
        <name>Hurd, David</name>
      </author>
      <author>
        <name>Ellis, Leslie R</name>
      </author>
      <author>
        <name>Harrelson, Robin</name>
      </author>
      <author>
        <name>Manuel, Megan</name>
      </author>
      <author>
        <name>Dralle, Sarah</name>
      </author>
      <author>
        <name>Lyerly, Susan</name>
      </author>
      <author>
        <name>Powell, Bayard L</name>
      </author>
    </item>
    <item>
      <title>Translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613</title>
      <link>https://escholarship.org/uc/item/3z71m0jv</link>
      <description>STUDY RATIONALE AND OBJECTIVES: Via genetic alterations, malignant transformation and proliferation are associated with extensive alterations of mitochondrial energy metabolism of tumor cells. Thus, inhibition of the altered form of mitochondrial energy metabolism of tumor cells may be an effective therapy for cancers. This study performed translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613.
METHODS: The gene profiles of BxPC-3 human pancreatic tumor cells and non-transformed NIH-3T3 mouse fibroblast cells (negative control), after CPI-613 or sham treatment, were assessed and compared using microarray technique. The anti-cancer efficacies of CPI-613 and Gemcitabine were assessed and compared in mice with xenograft from inoculation of BxPC-3 human pancreatic tumor cells, based on the degree of tumor growth inhibition...</description>
      <guid isPermaLink="true">https://escholarship.org/uc/item/3z71m0jv</guid>
      <pubDate>Fri, 29 Mar 2024 00:00:00 +0000</pubDate>
      <author>
        <name>Lee, King C</name>
      </author>
      <author>
        <name>Maturo, Claudia</name>
      </author>
      <author>
        <name>Perera, Candida N</name>
      </author>
      <author>
        <name>Luddy, John</name>
      </author>
      <author>
        <name>Rodriguez, Robert</name>
        <uri>https://orcid.org/0000-0003-1354-1773</uri>
      </author>
      <author>
        <name>Shorr, Robert</name>
      </author>
    </item>
  </channel>
</rss>
